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ABSTRACT 
Omega (n)-3 polyunsaturated fatty acids (PUFA) have beneficial effects in 
neuropsychiatric illnesses.  The goals of this thesis were to determine the effects of 
feeding diets varying in n-3 PUFA on brain fatty acid composition, and neurotrophin and 
myelin-related gene expression of the brain in an age, sex, and region-specific manner.  A 
diet high in n-3 PUFA altered phospholipid docosahexaenoic acid (DHA) and oleic acid 
composition in an age, sex, and region-specific manner.  Diet had no effect on the mRNA 
expression of brain-derived neurotrophic factor (BDNF) and tropomyosin-receptor 
kinase-B (TrkB); however, stearoyl-CoA desaturase-1 (SCD1) and myelin basic protein 
(MBP) gene expression increased in offspring fed a diet high in n-3 PUFA in an age, sex, 
and region-specific manner.  DHA treatment to ex vivo cerebral cortical cells showed an 
increase in BDNF, TrkB, SCD1, and MBP mRNA expression compared to control cells.  
The mRNA expression of BDNF and SCD1 was higher in DHA treated cells compared to 
arachidonic acid treated cells.  Overall, the data presented in this thesis suggests that the 
potential benefits of n-3 PUFA on brain function are sex, age and brain-region specific.   
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Chapter 1: Introduction 
 
1.1 Neuropsychiatric illnesses  
The increasing prevalence of neuropsychiatric illnesses is imposing a global 
economic burden surpassing that of cardiovascular disease and cancer (Collins et al., 
2011).  Commonly known examples of these conditions are depression, general anxiety 
disorder (GAD), autism, Alzheimer’s disease and schizophrenia (Miyoshi & Morimura, 
2009).  According to a report by the National Institute of Health in 2010 (Vos et al., 
2012), neuropsychiatric illnesses are ranked as the leading disorders to affect the global 
population.  When focusing on Canada, 12.6% of Canadians in 2012 met the criteria for 
having some mood disorder during their lifetime (Pearson et al., 2013).  Of these 
Canadians, depression accounted for 11.3% percent, whereas 8.7% reported symptoms 
consistent with that of GAD (Pearson et al., 2013).    
The rates of depression and GAD vary with sex: females suffer from depression 
and anxiety at a higher rate compared to males (Kessler, 1994).  Canadian women show a 
higher rate of depression than that of Canadian men, especially between the ages of 15 to 
24 (Pearson et al., 2013).  Moreover, the rates of occurrence of neuropsychiatric illnesses 
vary with age.  For example, the occurrence of GAD and depression is more prevalent in 
young adults (Pearson et al., 2013); however, the occurrence of Alzheimer’s disease is 
higher in persons of age 65 or older (Xu et al., 2010).  Thus, age and sex further add to 
the complexity of neuropsychiatric disorders. 
 
 
 ʹ
1.1.1 The complexity of the brain and neuropsychiatric illnesses 
The brain is a highly sophisticated and complex organ organized into several 
regions (Figure 1.1), which govern specific functions.  The morphological differences in 
various regions of the brain are due to the number, density, axonal branching, and 
synaptic connectivity of neurons (Bansal et al., 2015).  The brain also consists of non-
neuronal cells, known as glial cells, which maintain homeostasis, myelin formation, and 
provide support and protection for neuronal cells.  Glial cells are also capable to 
communicate with themselves and neurons through the release of neuroactive substances 
known as gliotransmitters (Navarrete et al., 2013; Martineau, 2013).  The variability in 
the size and number of glial cells, blood vessels, and the amount of extracellular space 
can contribute to the differences in brain morphology (Bansal et al., 2015).  Furthermore, 
it is suggested that variances in the morphology of different brain regions can be used to 
diagnose specific neuropsychiatric disorders (Bansal et al., 2012; Bansal et al., 2015).  
However, the majority of the studies assessing the function of the brain during periods of 
illness have focussed on the cerebral cortex; this is due largely to the extent and 
distribution of abnormal biochemical markers specifically in this region, compared to 
control subjects (Bowen et al., 1989).  
The cerebral cortex covers a vast area of the brain, which is separated into two 
hemispheres along the sagittal plane.  The cerebral cortex is further divided into many 
sub-regions, which play a role in memory, attention, language and higher-level 
perception. The cerebral outer layer is highly composed of neuronal cell bodies, forming 
a large outer gray matter area (Chavko et al., 1993; Söderberg et al., 1990).  However, the  
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Figure 1.1: Anatomical representation of the cerebral cortex, cerebellum and 
brainstem location in the brain.  
 Ͷ
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cerebral inner area contains an inner core of myelinated axons forming the white matter 
(Chavko et al., 1993; Söderberg et al., 1990).  When assessing the volume and size of the 
human brain, isotopic fractionation has shown the cerebral cortex to make up 
approximately 81.2% of the total brain mass; however, it only contains 19% of the brain’s 
neurons (Azevedo et al., 2009).  Furthermore, the ratio of glial cells to neurons for the 
cerebral cortex is 3.76, showing a higher population of glial cells than neurons (Azevedo 
et al., 2009).  
With the use of magnetic resonance imagining (MRI), studies have found 
associations between neuropsychiatric illnesses and the cerebral cortex (Canu et al., 2015; 
Zielinski et al., 2014).  Canu et al. (2015) has shown thinning of various sub-regions of 
the cerebral cortex in patients with major depression disorder (MDD) and GAD, 
compared to healthy subjects with no history of neuropsychiatric disorder.  In addition, 
autistic children were shown to have cortical thinning throughout mid-childhood 
compared to the brains of healthy children during the same developmental period 
(Zielinski et al., 2014), further highlighting the importance of the cerebral cortex in brain 
function.  Interestingly, there is increasing evidence supporting the role of the cerebellum 
in emotion and cognition (Schutter & Van Honk, 2005).  Disruptions in these functions 
are linked to several neuropsychiatric illnesses (Hoppenbrouwers et al., 2008).    
The cerebellum, also known as the “little brain”, is located ventrally posterior to 
the cerebral cortices (Figure 1.1).  Like the cerebral cortex, the cerebellum is divided into 
two hemispheres.  Most notably, the cerebellum controls motor function and learning, 
balance, and various cognitive functions.  The outside of the cerebellum is composed of 
gray matter, while the core is composed of white matter (Chavko et al., 1993; Söderberg 
 ͸
et al., 1990).  Compared to the cerebral cortex, the cerebellum, however, has a higher 
content of white matter (Chavko et al., 1993).  The human cerebellum makes up 10.3% of 
the total brain mass; however, it has four times the number of neurons than the cerebral 
cortex (Andersen et al., 1992; Azevedo et al., 2009).  In addition, the human cerebellum 
has a much lower number of glial cells than the cerebral cortex, with a glial cell to neuron 
ratio of approximately 0.23 (Azevedo et al., 2009).  Cerebellar dysfunction has been 
associated with multiple neuropsychiatric disorders, including autism, schizophrenia, 
mood disorders, and anxiety disorders (Greer et al., 2005; Courchesne et al., 1988; 
Bottmer et al., 2005).  In particular, neuroimaging studies assessing individuals with 
depression detected significant differences in both cerebellar structure and function 
(Bench et al., 1992; DelBello et al., 1999; Dolan et al., 1992).  Moreover, individuals 
suffering from autism have a loss and degeneration of cerebellar purkinje and granule 
cells (Vargas et al., 2005).    
Another vitally important region of the brain is the brainstem.  The brainstem is a 
region found ventral to the brain (Figure 1.1), continuous to that of the spinal cord.  It 
includes three subregions: 1) the medulla oblongata; 2) pons; and 3) midbrain.  The 
brainstem tract contains the main cranial nerve nuclei, which innervate various regions of 
the body, including regions of the respiratory and circulatory system.  Most importantly, 
the brainstem is the route by which motor and sensory information is carried to and from 
the central nervous system (CNS) to the periperheral nervous system (PNS).  Compared 
to the cerebral cortex and cerebellum, the brainstem consists of mostly white matter; 
however, it also includes clusters of gray matter (Chavko et al., 1993; Fernandez-Gil et 
al., 2010).  In addition, the human brainstem contains less than 1% of the total brain 
 ͹
neurons; however, the glial cell to neuron ratio is approximately 11.35 (Azevedo et al., 
2009).  Brainstem-related symptoms, such as gait and balance impairment (Golbe, 2001), 
as well as depression (Rub et al., 2000) in Alzheimer’s patients suggests the brainstem to 
play a role in the pathogenesis of Alzheimer’s disease (Morcinek et al., 2013).  These 
symptoms have been linked to the build-up of tau proteins, a hallmark of Alzheimer’s 
disease, in the brainstem (Simic et al., 2009).  Therefore, the brainstem also plays a 
specific role in the development of neuropsychiatric illnesses.   
1.1.2 Neurotrophins and neuropsychiatric illnesses  
A group of secreted trophic factors in the brain, known as neurotrophins, are 
required for neuronal differentiation, survival and growth (Huang & Reichardt, 2001).   
The four main neurotrophins in the brain are brain-derived neurotrophic factor (BDNF), 
nerve growth factor (NGF), neurotrophin-3, and neurotrophin-4/5 (Park & Poo, 2013).  
Neurotrophins begin their actions during gestation; however, the role and activity of 
neurotrophins varies throughout different stages of growth and development (Birling & 
Price, 1995).  Neurotrophins are necessary for the proper growth and development of the 
CNS, where they play a vital role in synaptogenesis, synaptic plasticity, neuronal survival 
and neurogenesis (Chao et al., 2006).  The upregulation of neurotrophins was shown to 
alleviate the symptoms of neuropsychiatric disorders (Razavi et al., 2015; Chao et al, 
2006).  
1.1.3 BDNF and brain function   
Among all neurotrophins in the brain, BDNF is one of the main secretory proteins 
in the CNS (Chao et al., 2006).  A dysfunction in the expression of BDNF was previously 
shown to render significant deficits in neuronal signalling activities (Mariga et al., 2015).  
 ͺ
Furthermore, reduced BDNF expression predisposed humans and rodents to have an 
altered cognitive-behavioural functions, as well as increasing their risk for 
neuropsychiatric illnesses (Castrén & Rantamäki, 2008; Chen et al., 2006).  BDNF is first 
translocated into the endoplasmic reticulum as a precursor protein pre-proBDNF (Mowla 
et al., 1999).  The pre-signalling sequence is then cleaved to render proBDNF, which is 
transported to the Golgi; the proBDNF is then cleaved by furin and endoprotease into an 
approximately 14 kilodalton (kDa) mature BDNF (mBDNF) (Mowla et al., 1999).  
Cleavage of proBDNF into mBDNF can also occur in secretory granules by convertases 
before being exocytosed into the synaptic cleft (Mowla et al., 1999).  BDNF expression 
was shown to be stimulated with or without an increase in neuronal activity (Bramham, 
2008; Bramham & Messaoudi, 2005).  Once secreted, mBDNF can bind to its high-
affinity receptor tropomyosin-receptor kinase B (TrkB), promoting an intracellular 
signalling cascade (Figure 1.2) (Kaplan & Miller, 2000).  Upon binding, TrkB dimerizes 
and autophosphorylates, which initiates downstream phosphorylation of several proteins 
involved in the PI3K/Akt pathway, Ras/Raf pathway, and the cAMP response element 
binding protein (CREB) (Kaplan & Miller, 2000).  Phosphorylation of CREB then leads 
to the transcription of genes involved in neuronal survival, neurogenesis and synaptic 
plasticity (Kaplan & Miller, 2000).  
The importance of BDNF during development was established using a BDNF 
knockout mouse that developed brain abnormalities, and died soon after birth (Ernfors et 
al., 1994).  In addition, mice lacking fully functional hippocampal TrkB signalling during 
neuronal development showed an increase in anxiety-like behaviours in later life 
(Bergami et al., 2008).  Thus, abnormalities in mBDNF synthesis, release, and signalling  
 ͻ
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: BDNF signal transduction pathway. BDNF binds to its high-affinity 
receptor tropomyosin-receptor kinase B (TrkB) to initiate the activation of 
Ca2+/calmodulin-dependent protein kinase (CAMKII), protein kinase A (PKA), 
protein kinase B (PKB) AKT, and extracellular-signal-regulated kinase (ERK) 
pathways.  This leads to phosphorylation of cAMP response element-binding 
protein (CREB), which enters the nucleus and activates transcription of genes 
involved in neurogenesis, neuronal survival, synaptic plasticity, and cognition and 
memory.  (Adapted from Kaplan & Miller, 2000, Current Opinions in 
Neurobiology, 10; 381)   
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have been shown to be a culprit in the development of neuropsychiatric illnesses (Rehn & 
Rees, 2005; Chen et al., 2006).  Patients with MDD showed reduced serum protein levels 
of mBDNF (Matrisciano et al., 2009), which was mitigated with antidepressants (Castrén 
& Rantamäki, 2010).  Our laboratory has previously established that dietary factors, such 
as omega (n)-3 polyunsaturated fatty acids (PUFA), increase the gene expression of 
mBDNF (Balogun & Cheema, 2014); however, the exact mechanism is still not clear.  
1.1.4 Risk factors associated with neuropsychiatric illnesses  
Multiple factors, such as genetics, sex, and environment can play critical roles in 
neuropsychiatric illnesses.  Furthermore, sex-specific differences related to structural and 
hormonal differences between males and females add to the complexity of 
neuropsychiatric illnesses (Bao & Swaab, 2010).  A recent meta-analysis found that males 
have 8-13% larger brain volumes compared to females (Ruigrok et al., 2014).  
Furthermore, MRI studies have also shown that various regions of the brain differ in size 
and volumes between adult males and females (Goldstein et al., 2001; Ruigrok et al., 
2014).  
Environmental factors may play an important role in the development of 
neuropsychiatric illnesses.  Among the many environmental factors, nutritional status 
during critical periods of brain development was shown to affect the outcomes of the 
offspring’s mental health (Jacobson et al., 2008; Crawford, 1992; Weiser et al., 2015).  
The brain is largely composed of lipids; 60% of the brain’s structural material is lipid  
(Crawford, 1992).  Studies have shown that the amount and type of dietary fatty acids can 
affect the lipid composition of various regions of the brain, thereby influencing the onset 
of neuropsychiatric illnesses in later life (Bhatia et al., 2011; Balogun & Cheema, 2014). 
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1.2 Fatty acid composition of the brain  
Fatty acids in the brain come from the peripheral circulation, and are either 
derived from the diet or from hepatic de novo synthesis (Legarde et al., 2001; Theis et al., 
1994).  In addition, the brain is also capable of synthesizing fatty acids (Aeberhard & 
Menkes, 1967).  The majority of the saturated fatty acids (SFA) in the neuronal 
membrane phospholipids (PLs) of the brain are palmitic acid (C16:0) and stearic acid 
(C18:0), making up approximately 19% and 17% of total SFA, respectively (Edmond et 
al., 1998; McNamara & Carlson, 2006).  The most abundant monounsaturated fatty acids 
(MUFA) are oleic acid (C18:1) and eicosenoic acid (C20:1n-9), comprising of 
approximately 19% and 1% of total MUFA, respectively (Edmond et al., 1998; 
McNamara & Carlson, 2006).  Finally, the most abundant PUFAs in the brain are the n-3 
PUFA docosahexaenoic acid (DHA; C22:6n-3) and the n-6 PUFA arachidonic acid (AA; 
C20:4n-6) (Martínez & Mougan, 1998).  DHA and AA account for 50% and 40% of the 
total PUFAs in the brain, respectively (Lauritzen et al., 2001).  In general, the brain is 
composed of these SFAs, MUFAs and PUFAs, but various regions of the brain differ in 
their specific fatty acid compositions.   
1.2.1 Region-specific differences in the fatty acid composition  
The neuronal membrane is highly enriched in lipids, particularly PLs 
(Svennerholm, 1968).  The PLs that primarily make-up the neuronal membrane are 
phosphatidylcholine (PC), phosphatidylinositol (PI), phosphatidylserine (PS), 
phosphatidylethanolamine (PE), and sphingomyelin (Sph) (Svennerholm, 1968).  In 
addition, PC and PE are the most abundant PLs in the neuronal membranes of an adult 
whole brain (Sun & Horrocks, 1967).  There is only one study to date to show that the 
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fatty acid composition of the specific PLs of the brain can change during development 
and in later life (Svennerholm, 1968).  In this study, it was reported that the gray matter 
PE contains C18:0 as the most abundant fatty acid at all ages; although, in white matter 
PE, C18:1 made up over 40% of four year-old children’s and adult’s brains, while C18:0 
comprised only about 10%.  Interestingly, white matter PE was shown to have a sparse 
amount of DHA after childhood and it did not increase with age. Furthermore, gray 
matter PC esterified with DHA increased with age; however, in white matter PC, DHA 
and AA decreased with age.  This study only attributes the age-specific effects of the 
specific PL fatty acid composition to white and gray matter from the cerebral cortex.  
However, we postulate the specific PL fatty acid compostion of the cerebellum, cerebral 
cortex, and brainstem will differ due to the differences in the regional composition of 
gray and white matter.  As previously mentioned, the brainstem has the highest amount of 
white matter, followed by the cerebellum and then cerebral cortex (Chavko et al., 1993).  
White matter is highly enriched with SFA and MUFAs, and depleted of PUFAs, which is 
due to the region-specific differences in the specific PL species (Kishimoto et al., 1969).  
Thus, the regional and age-related fatty acid composition of the brain appears to pertain to 
that of the content of white versus gray matter.  It would be important to know the age-
related regulation of the specific PL fatty acids of different regions of the brain, as the 
development of various regions of the brain is age dependent.  In addition, whether the 
specific fatty acid composition of different regions of the brain can be altered by 
environmental factors, such as diet, and whether age plays an important role is not 
known.   
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1.2.1.1 Effect of age on brain spatial fatty acid composition 
A handful of studies have shown age specific effects on the fatty acid composition 
of the brain.  A study by Xiao et al. (2005) found that the cerebral cortex from 3-day-old 
rat pups had similar percentages of approximately 11.0% DHA in the cerebral cortex, 
cerebellum, and brainstem PLs; however, at postnatal day 21, the PL DHA was higher in 
the cerebral cortex (15.3%) than the cerebellum (13.8%) and brainstem (13.6%).  This 
trend of regional DHA distribution carried into the adult-life, and it stayed significantly 
higher in the cerebral cortex compared to the cerebellum and brainstem, while the amount 
of AA remained similar in all regions of the brain and decreased with age.  However, 
Carrié et al. (2000) has reported that the amount of AA was highest in the cerebral cortex 
compared to the brainstem and cerebellum in the adult brain.  The amount of SFA and 
MUFA has also been shown to vary with age.  The adult mouse cerebral cortex has a 
higher amount of SFA, particularly C18:0, followed by the cerebellum and brainstem 
(Carrié et al., 2000).  Furthermore, C16:0 levels were similar in the cerebral cortex, 
cerebellum, and brainstem; however, C16:0 decreased with age (Xiao et al., 2005).  The 
amount of C18:1 was higher in the brainstem and cerebellum compared to the cerebral 
cortex, and it increased with age in all regions of the brain (Carrié et al., 2000; Xiao et al., 
2005).  During development and throughout life, SFAs and MUFAs have been shown to 
serve important structural and physiological functions (O’Brien & Sampson, 1965; 
Rodriguez-Rodriguez et al., 2004).  These include the formation of the myelin sheath 
(Edmond et al. 1998; Muse et al. 2001), dendritic differentiation (Rodriguez-Rodriguez et 
al., 2004), and inflammation (Kwon et al., 2014).  Thus, understanding the synthesis  of 
SFAs and MUFAs is vitally important. 
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1.2.2 SFA and MUFA synthesis and their functions in the brain  
Oligodendrocytes have the capacity to synthesize the requirement of SFAs and 
MUFAs for the neuronal membrane PLs (Garbay et al., 1997).  Therefore, the synthesis 
of SFAs and MUFAs in the brain is independent of exogenous SFAs and MUFAs in the 
circulation (Edmond et al., 1998).  In the brain, C16:0 is the final product of fatty acid 
synthase (Figure 1.3), which can be elongated to make C18:0; these two SFAs can then 
be desaturated via delta-9 desaturase or stearoyl-CoA desaturase-1 (SCD1) to synthesize 
MUFAs.  The main MUFAs produced after desaturation are C16:1n-7 from C16:0, C18:1 
synthesized from C18:0, and C20:1n-9 from the elongation of C18:1 by elongase-6.  
During development, there is a rapid accumulation of SFAs and MUFAs in the brain, 
along with an increased activity of the rate-limiting enzyme SCD1 to form more MUFAs 
(DeWille & Farmer, 1992).  Interestingly, studies assessing brain PL fatty acid 
composition after feeding diets varying in C18:1 found no change in C18:1 PL fatty acid 
composition (Rioux & Innis, 1992; Bourre & Dumont, 2003; Edmond et al., 1998).  
Therefore, brain C18:1 production may come from SCD1-mediated production, as 
opposed to uptake from circulation.  MUFAs are needed by the brain as a source of 
energy, ligands for various physiological functions (German, 2011) and the synthesis of 
PLs for the developing neuronal membrane (Lengi & Corl, 2015).  Furthermore, there is a 
rapid production and accumulation of MUFAs, primarily C18:1 and C20:1n-9 during 
brain development for the formation of myelin sheath (Svennerholm, 1968).  During the 
first 12-30 days after birth in rodents, the CNS oligodendrocytes promote massive 
synthesis of long-chain SFAs and MUFAs to promote the formation of the myelin sheath 
(Edmond et al., 1998; Muse et al., 2001).   
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Figure 1.3: Pathways for biosynthesis of saturated and monounsaturated fatty acids in 
the brain.  Palmitic acid (C16:0) is the main end product of brain fatty acid synthase 
which can be elongated and desaturated to form C16:1n-7, C18:1, and C20:1n-9.  
Stearoyl-CoA desaturase-1 (SCD1) is the rate-limiting enzyme for the desaturation of 
C16:0 and C18:0.  ELOVL6 = elongase-6; ELOVL3 = elongase-3   
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Myelin sheath formation in the rodent brain occurs between days 10-12 after birth, 
with a maximal rate of formation at day 20 (Cuzner & Davison, 1968).  In particular, 
C18:1 is an important fatty acid for proper myelin sheath formation during development 
and later life (Rioux & Innis, 1992; Bourre & Dumont, 2003).  In fact, 20-40% of the 
total fatty acids that comprise the myelin sheath are C18:1 (Norton & Cammer, 1984), 
and neuronal membrane C18:1 increases with the development of myelin (Garbay et al., 
1998).  Thus, any alterations in the rate of synthesis of MUFAs and SFAs in the brain will 
affect the brain fatty acid composition.   
A dysregulation in fatty acid homeostasis was associated with neuropsychiatric 
disorders (Lin et al., 2010; Hamazaki et al., 2012; Hamazaki et al., 2013).  In particular, 
significantly higher amounts of C16:0 and lower amounts of C18:1 were found in the 
amygdala from post-mortem MDD patients compared to control subjects (Hamazaki et 
al., 2012).   
A possible explanation for this alteration is thought to be due to changes in SFA 
and MUFA biosynthesis in the brain of MDD patients (McNamara & Liu, 2011).  
Specifically, there is only one human study to date to show a reduction in the mRNA 
expression of SCD1 in the prefrontal cortex of patients with MDD (McNamara & Liu, 
2011).  McNamara & Liu (2011) promote the importance of SFA and MUFA 
biosynthesis in the brain via SCD1, but more research needs to be undertaken.  In 
addition, it is not clear whether the synthesis of SFA and MUFA in different regions of 
the brain is differentially regulated.  
1.2.3 N-3 and n-6 PUFA in the brain  
Although the brain can synthesize its own SFAs and MUFAs, PUFA synthesis 
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and transport to the brain is still debatable.  Several mechanisms have been postulated for 
the entry of PUFAs into the brain from peripheral circulation (Figure 1.4).  It has been 
suggested that PUFAs arrive at the blood brain barrier (BBB), a highly selective 
endothelial barrier, in either a non-esterified or esterified form (Lagarde et al., 2001).  
Esterified PUFAs can arrive to the BBB as lysophosphatidylcholine (LPC) attached to 
albumin (Thies et al., 1994), or by lipoproteins packaged in the liver (Spector, 2001).  
However, whether or not lipoproteins are involved in the transport of PUFA for the brain 
remains controversial (Chen et al., 2008; Williams et al., 1997).  The controversy arises 
from the biological relevance of PUFA lipoprotein transport to the brain, as LDL (Chen et 
al., 2008) and VLDL (Rahman et al., 2010) receptor knock-out mice shown no changes in 
brain PUFA regulation.  DHA, which is esterified to LPC, is more efficiently transferred 
than the non-esterified form (Bernoud et al., 1999).  However, non-esterified fatty acids, 
derived from adipose tissue stores attached to albumin and lipoproteins, have also been 
shown to contribute to brain n-3 and n-6 PUFA pool (Thies et al., 1994; Brecher & Kuan, 
1979; Ouellet et al., 2009).  The recent discovery of the major-facilitator superfamily 
domain-containing protein-2 (Mfsd2a) has established that Mfsd2a transports the majority 
of DHA in the form of LPC to the brain (Nguyen et al., 2014). 
The brain is also capable of synthesizing DHA endogenously via endothelial cells 
comprising the BBB and neuroglial cells known as astrocytes (Moore et al., 1990).  These 
cells are capable to begin the initial elongation and desaturation of the essential n-3 PUFA 
alpha-linolenic acid (C18:3n-3;ALA) (Moore et al., 1990).  The essential fatty acids ALA 
and linoleic acid (C18:2n-6; LA) go through desaturation and elongation to make longer-  
chain fatty acids by sharing the same desaturase and elongase enzymes (Figure 1.5).   
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Figure 1.4: The omega-3 and - 6 PUFA transport across the blood brain barrier.  
PUFAs can be transported to the brain esterified to lipoproteins or they can be 
transported to the blood brain barrier esterified to lysophosphatidylcholine (Lyso-PC) 
or as non-esterified fatty acid attached to albumin.  Lyso-PC can be transported across 
the BBB via the major-facilitator superfamily domain-containing protein-2 (Mfsd2a).  
NE-PUFA = non-esterified polyunsaturated fatty acid; E-PUFA = esterified 
polyunsaturated fatty acid; LDL-R = Low-density lipoprotein receptor.   (Adapted from 
Liu et al., 2015, Brain Research, 1597:220)  
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Figure 1.5: The omega-3 and -6 PUFA synthesis from the essential fatty acids.  Alpha-
linolenic acid (ALA) and linoleic acid (LA) from the diet are desaturated and elongated to 
longer-chain fatty acids via the same desaturases and elongases.  DHA = docosahexaenoic 
acid; AA = arachidonic acid; EPA = eicosapentaenoic acid (Adapted from Liu et al., 2015, 
Brain Research, 1597:220)  
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Once desaturated and elongated, DHA and AA are released into the surrounding 
cerebrospinal fluid, where both can be used by the brain for various structural and 
physiological roles (Moore et al., 1990; Crawford, 1992; Bhatia et al., 2011).  However, 
when tracking the entry of radiolabelled ALA into the brain, it was completely 
metabolized via -oxidation into aqueous -oxidation products (DeMar et al., 2005).  
This renders a conversion of less than 0.2% of ALA into DHA (DeMar et al., 2005).  As 
opposed to a low conversion of ALA to DHA, LA was shown to be converted to AA with 
an efficiency of approximately 15% in the brain (Green & Yaven, 1993).  Thus, it appears 
that the brain depends on the exogenous supply of PUFA, such as AA and DHA, rather 
than the endogenous synthesis.  
1.2.3.1 Role of n-3 and n-6 PUFAs in the brain 
 During development, there is a large accumulation of DHA and AA that is critical 
for the proper functioning and development of the mammalian CNS (Xiao et al., 2005; 
Stillwell et al., 2005).  Recent studies using radiolabelled fatty acids for the use of 
positron emission tomography (PET) have made human brain PUFA studies achievable 
(Thambisetty et al., 2012; Umhau et al., 2013).  After intravenously infusing 
radiolabelled non-esterified DHA into healthy adult patients and using the PET method, 
Umhau et al. (2009) found that a greater amount of DHA was taken up by the gray matter 
compared to the white matter neuronal membrane PLs from the whole brain.  These 
levels of DHA incorporation may represent active DHA metabolism during 
synaptogenesis and active neurotransmission (DeGeorge et al., 1989; Jones et al., 1996).  
DHA and AA compete for neuronal membrane placement, thus, the higher intake of n-6 
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PUFA can render a greater accretion of AA thereby altering membrane functionality.  
After infusing radiolabelled AA into the plasma of healthy adults, the PET scan showed 
greater accretion of AA in gray matter compared to white matter (Giovacchini et al., 
2002).  PET studies on healthy human adult brains have further established that the 
uptake of radiolabelled AA is higher than that of radiolabelled DHA (Giovacchini et al., 
2004); patients with Alzheimer’s disease showed a further increase in the uptake of AA 
compared to DHA (Esposito et al., 2008).  DHA and AA are mobilized from the sn-2 
position of the neuronal membrane PLs via the action of phospholipases (Farooqui et al., 
2004).  They have the capability to modulate signalling pathways through their 
association with the neuronal membranes and synapses (Murphy, 1985).  For example, 
studies have shown that PUFAs interact with pathways responsible for the regulation of 
neurotransmitters (Owens & Innis, 1999), neurotrophins (Balogun & Cheema, 2014), 
myelin formation (Peters et al., 2012), and neuronal survival (Akbar, 2005).   
It is important to note that n-6 and n-3 PUFAs elicit different physiological 
functions in the brain.  More specifically, when assessing the effects of both DHA and 
AA on rat neural stem cells, only DHA treatments increased the rate of rat neural stem 
cell differentiation (Katakura et al., 2013).  Another study assessing the effects of AA and 
DHA on ex vivo rat cerebral cortical cells showed DHA treatment reduced the uptake of 
the neurotransmitter glutamate by cortical astrocytes (Grintal et al., 2009); however, AA 
had no effect.  Thus, an imbalance in the intake of dietary n-3 and n-6 PUFA may alter 
the proportion of n-3 and n-6 PUFA in the brain, which may then lead to an alteration in 
the functioning of the brain.   
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1.3  Importance of dietary n-3 and n-6 PUFA in the brain  
Recent evidence shows that the fatty acid composition of the brain can be changed 
by dietary lipids (Bhatia et al., 2011).  Since brain SFA and MUFA are automonous to 
dietary intake, most studies have focused on the importance of dietary PUFAs in brain 
development and their involvement in the underlying pathogenesis of neuropsychiatric 
disorders (Carrié et al., 2000; Bhatia et al., 2011).  The main PUFAs in the brain are 
DHA and AA, which account for 50% and 40 % of the brain total PUFA, respectively 
(Lauritzen et al., 2001).  The maintenance of this fatty acid profile, mostly through 
dietary PUFAs, is very important for the proper functioning of the brain (Chung et al., 
2008; Rao et al., 2007).  Many studies have aimed to determine the beneficial effects of 
n-3 PUFA on the brain (Carrié et al., 2000; Bhatia et al., 2011), especially because the 
dietary intake of n-3 PUFA has been declining in the Western society.  Since the 
industrialization of the modern world, dietary imbalance has shifted the intake of n-6 to n-
3 PUFAs ratio of 1:1 from the Hunter-Gatherer time to approximately 20:1 in a typical 
North American diet (Simopoulos, 2011).  Evidence shows that countries with lower fish 
intake have a higher rate of bipolar disorder and post-partum depression, compared to 
countries that have higher intakes of fish (Noaghiul & Hibbeln, 2003; Hibbeln, 2002), 
suggesting the importance of dietary n-3 PUFA in maintaining proper brain function.  
Studies suggest this may be due to altering the brain fatty acid DHA/AA ratio, which then 
will alter the biological function of the neuronal membrane (Bhatia et al., 2011; Balogun 
& Cheema, 2014).  However, most studies determining the biological outcome from 
changing the DHA/AA ratio of the neuronal membrane focus mainly on the cerebral 
cortex and hippocampus (Balogun & Cheema, 2014; Bhatia et al., 2011; Rao et al., 
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2007).  Unlike the cerebellum and brainstem, both these regions of the brain are highly 
enriched in PS and PE esterified with DHA (Svennerholm, 1968; Chavko et al., 1993).  
Therefore, the potential benefits from altering the PL DHA/AA ratio may be specific to 
the PL class of the neuronal membrane.  However, it is not known whether altering the 
DHA/AA ratio in the cerebellum and brainstem will alter any biological outcome.  
During the last trimester of pregnancy and throughout lactation, the brain is 
rapidly developing, and there is a high demand for DHA for development of the neuronal 
membrane (Martinez, 1992).  Once established, the neuronal membrane PL fatty acid 
composition is quite rigid throughout life and typically remains unchanged; however, n-3 
PUFA dietary supplementation can have a huge impact on the membrane fatty acid 
profile.  Most of the PUFA used for neuronal membrane synthesis originates from dietary 
DHA and AA (Clandinin et al., 1980).  Our laboratory has previously shown that feeding 
a diet high in n-3 PUFA to mice caused an increase in the cerebral cortex DHA (Balogun 
& Cheema, 2014).  A study assessing baboon neonates showed feeding a diet enriched 
with DHA for 4-months after birth increased the accretion of DHA in the cerebral cortex 
(Hseih et al., 2007).  The brain, however, is composed of several regions that serve 
different functions, and there are only a handful of studies to show the effect of a diet 
high in n-3 PUFA on the fatty acid composition of different regions of the brain (Xiao et 
al., 2005; Carrie et al., 2000).  Furthermore, these studies did not investigate age specific 
effects of a diet high in n-3 PUFA on the fatty acid composition of various regions of the 
brain.  This is vitally important because as the brain ages the region-specific PL fatty acid 
composition of brain changes (Martinez, 1992; Xiao et al., 2005); thus it would be 
important to investigate whether a diet high in n-3 PUFA would induce alterations in fatty 
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acid composition in an age and brain region-specific manner.   
 Studies have indicated that altered brain development during the perinatal period 
is consequentially a high risk factor for the development of neuropsychiatric illnesses 
(Barlow et al., 2007; Miller & O’Callaghan, 2008; Palubinsky et al., 2012).  The 
upregulation of neurotrophins mitigates the symptoms of neurological illnesses (Huang & 
Reichardt, 2001).  Moreover, alterations in the synthesis and release of neurotrophins has 
been shown to be involved in the development of neuropsychiatric illnesses (Rehn & 
Rees, 2005).  In recent years, one of the effects induced by DHA in the brain has been 
shown to be the regulation of the BDNF signalling pathway (Rao et al., 2006).       
1.3.1 Dietary n-3 PUFA and BDNF regulation  
Studies assessing the effects of n-3 PUFAs on depression and anxiety in humans 
have found a positive correlation between n-3 PUFA intake and serum BDNF levels 
(Ferreira et al., 2014).  Furthermore, rodent models of depression and anxiety have found 
a reduction in anxiety and depression like symptoms, and an increase in BDNF 
expression after fish oil supplementation (Arbabi et al., 2014; Mizunoya et al., 2013).  An 
increase in the maternal consumption of n-3 PUFA showed an increase in the levels of 
BDNF in their offspring (Weiser et al., 2015).  Our laboratory has previously established 
that feeding varying amounts of dietary n-3 PUFA to females during pregnancy altered 
the cortical fatty acid composition of the offspring (Balogun & Cheema, 2014).  This 
alteration in neuronal membrane fatty acid composition is due to the competition between 
n-6 and n-3 PUFA for incorporation in the membranes.  Others have shown that a diet 
deficient in n-3 PUFA during the perinatal and postnatal period decreased BDNF protein 
expression in the male rat offspring hypothalamus and hippocampus (Bhatia et al., 2011).  
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In addition, this was associated with higher anxiety-like behavior compared to their 
counter parts fed a high n-3 PUFA diet (Bhatia et al., 2011).  Multiple studies have tried 
to elucidate the underlying mechanisms by which DHA increases the expression of 
BDNF.  Rats fed a diet deficient in n-3 PUFA for 15 weeks exhibited a decrease in the 
phosphorylation of the p38 mitogen-activated protein kinase (MAPK), CREB DNA 
binding activity, and ultimately BDNF expression in the frontal cortex (Rao et al., 2006).  
Our laboratory has previously shown that a maternal diet high in n-3 PUFA increased the 
phosphorylation of CREB in the offspring cortex compared to the low n-3 PUFA group 
(Balogun & Cheema, 2014).  Rao et al. (2006) established DHA treatment to primary rat 
cortical astrocytes increased the BDNF protein expression, which was shown to be via the 
p38 MAPK pathway.  However, it is not clear whether the regulation of BDNF is specific 
towards DHA, or can be regulated by other fatty acids.  In addition, no study to date has 
characterized the relationship between DHA and BDNF expression in different regions of 
the brain.    
Most studies assessing the effects of DHA on the brain have focused on the 
cerebral cortex and hippocampus as the region of choice (Avramovic et al., 2013; Chang 
et al., 2015; Firlag et al., 2013; Bhatia et al., 2011; Rao et al., 2006).  This may be due to 
the functionality of these regions, as both play a role in higher level thinking, short, 
working and long-term memory, and because most behavioural and cognitive symptoms 
associated with neuropsychiatric illnesses coincide with the functions of these regions.  
However, the brainstem and cerebellum have also been linked to the development of 
various neuropsychiatric diseases (Morcinek et al., 2013; Marinova et al., 2015).  Thus, it 
will be important to determine if a diet high in n-3 PUFA will alter BDNF expression in a 
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region-specific manner. 
1.3.2 The effects of dietary n-3 PUFA on the myelin sheath 
Studies have correlated a higher intake of fish or fish oil supplements with a 
significant increase in the quality of life for those with multiple sclerosis (Jelinek et al., 
2013), which is a neurodegenerative disease rendering the deterioration of the myelin 
sheath.  Furthermore, the beneficial effects of fish oil on the progression of multiple 
sclerosis have been shown to improve the future outcomes for newly diagnosed patients 
throughout their clinical course (Nordvik et al., 2000).  The positive effects of n-3 PUFA 
on protection of myelin are thought to be due to the stimulation of the myelinogenesis 
process (Salvati et al., 2008).  Interestingly, an in vitro study supplementing 
oligodendroglia cells with n-3 PUFAs have found an increase in their differentiation (van 
Meeteren et al., 2006).  This would be very important for myelin formation, as 
oligodendroglia cells are responsible for this process in the CNS (Baumann & Pham-
Dinh, 2001).  Another factor that is vitally important in the formation of the myelin 
sheath is the myelin basic protein (MBP) (Boggs, 2006). 
MBP is the second most abundant protein in the CNS myelin and it comprises 
30% of the total protein (Boggs, 2006).  MBP is the only structural protein found thus far 
to be essential for the formation of myelin (Boggs, 2006), and is accepted as the 
'executive molecule of myelin' (Moscarello, 1994).  MBP is a positively charged protein, 
with a molecular mass of  approximately 18.5 kDa (Boggs, 2006).  MBPs positive 
charged allows MBP to interact with the oligodendroglial negatively charged PLs (Müller 
et al., 2013).  The interaction between the oligodendroglial PLs and MBP has been 
proposed to compact myelin membranes (Müller et al., 2013).  Shiverer (shi) mice lack 
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the functional MBP, due to a autosomal recessive mutation, which renders a 
hypomyelination within the CNS, shivering symptoms, and eventually a premature death 
(Readhead & Hood, 1990).  Injecting 10 mM eicosapentaenoic acid (EPA; C20:5n-3) and 
DHA intracerebroventricularly into rat pup brains showed an increase in the mRNA 
expression of MBP in the cerebellum and medulla, compared to the control animals 
(Salvati et al., 2008), thus supporting the importance of n-3 PUFA in MBP regulation and 
myelin development.  After myelin maturation during development, the adult CNS has 
the propensity to remyelinate itself after a demyelinating injury occurs; however, this 
mechanism is less understood (Gallo & Deneen, 2014).  Adult mice suffering from a 
traumatic brain injury who were fed a diet high in n-3 PUFA two months prior to the 
injury had reduction in the loss of MBP compared to animals fed a diet low in n-3 PUFA 
diet (Pu et al., 2013), suggesting protective effects of a diet high in n-3 PUFA on the 
myelin sheath of the brain.  However, whether a diet high in n-3 PUFA will show 
different effects on myelin formation is not known.  In addition, it is important to 
establish whether a diet high in n-3 PUFA has region-specific regulation of MBP gene 
expression.  
1.4 N-3 PUFA on brain structure and function: effects of sex and age 
 Studies have shown that females have a higher tissue accumulation of n-3 PUFAs 
compared to males (Decsi & Kennedy, 2012; Extier et al., 2010).  This is due to a higher 
conversion rate of ALA to DHA (Decsi & Kennedy, 2012) in females because the key 
rate-limiting enzymes, delta-5 and delta-6 desaturases, have a higher expression in 
females (Extier et al., 2010).  Isotope studies have clearly revealed young women are 
more efficient at converting ALA into the longer chain metabolites DHA and EPA 
 ͵ʹ 
(Burdge & Wootton, 2002; Burdge et al., 2002).  Furthermore, a study assessing both 
male and female adults from the United States found that a high n-3 PUFA status was 
linked to a much slower progression of depressive symptoms in women compared to men 
(Beydoun et al., 2015).  This sex-specific n-3 PUFA tissue distribution and metabolism is 
thought to be due to estrogen (Childs et al., 2008); 17β-estradiol treatment has been found 
to increase the formation of ALA to EPA and DHA (Alessandri et al., 2008).  The female 
estrogens are well documented for their association with depression (Studd, 2011).  
Furthermore, estradiol has been shown to upregulate the gene expression of lipid 
metabolism genes (Alessandri et al., 2008).  FADS, ELOVL, and SCD1 have been shown 
to be regulated by estradiol, consequently leading to an increase in the rate of desaturation 
and elongation of their respective fatty acids (Alessandri et al., 2008; Marks et al., 2013).  
Women suffer from depression more frequently than men, especially during periods of 
hormonal fluctuation, such as the premenstrual, postpartum, and menopausal periods 
(Noble, 2005).  Moreover, estrogens have also been shown to play a vital role in neuronal 
protection and survival, along with enhancing synaptic plasticity and synaptogenesis 
through its interactions with the neurotransmitters dopamine and serotonin (Maki & 
Dumas, 2009; Mateos et al., 2012).  In addition, estrogens have also been shown to 
increase the expression of BDNF (Mateos et al., 2012), and increase the phosphorylation 
of its down-stream transcription factor CREB in the hippocampus of ovariectomized rats 
(Panickar et al., 1997).  Estrogens mediate their biological function through activation of 
the extranuclear estrogen receptor, which leads to the induction of the 
ERK/AKT/CREB/BDNF pathway in the hippocampus (Yang et al., 2010).  Furthermore, 
ovariectomized rats injected with estrogen and fed a diet high in n-3 PUFA showed a 
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synergistic effect on antidepressant-like behaviour and CREB activation in the 
hippocampus (Jin & Park, 2015).  Thus, estrogen plays a role in BDNF signalling in the 
brain; however, it is not known whether this interaction is dependent on the specific 
region of the brain.  Neuropsychiatric illnesses have been shown to have region and sex-
specfic effects (Beydoun et al., 2015; Morcinek et al., 2013; Greer et al., 2005).  
Furthermore, abnormalities in BDNF synthesis and release has been shown to be the 
culprit in the development of mulitple neuropsychiatric symptoms (Rehn & Rees, 2005).  
Therefore, it would be important to know whether BDNF expression differs in a sex and 
region specific manner.     
Although the effects of sex on the regulation of n-3 PUFA in the brain are quite 
noteable, age has also been shown to have an effect on n-3 PUFA metabolism in the 
brain.  As the human brain develops during the last trimester of pregnancy, the fetal brain 
begins to rapidly accumulate DHA (Martinez, 1992).  This continues throughout the first 
2 years of life, although the postnatal DHA accumulation occurs more slowly, compared 
to the DHA accumulation during perinatal period (Moriguchi & Harauma, 2013).  In 
rodents, this period of rapid brain growth and DHA accumulation is between prenatal day 
7 to postnatal day 16 (Green et al., 1999).  When assessing the effects of dietary n-3 
PUFA on DHA accumulation during brain development, human studies found prenatal 
and postnatal n-3 PUFA supplementation had inconsistent results, showing either 
beneficial effects or no neurodevelopmental effects (Henriksen et al., 2008; Isaacs et al., 
2011).  However, animal studies have provided information that supports the beneficial 
effects of a diet high in n-3 PUFA on brain development (Luchtman & Song, 2013; 
McNamara & Carlson, 2006).  Moreover, studies found the brain fatty acid composition 
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of rodents to change after feeding a diet high in n-3 PUFA (Ozias et al., 2007; Balogun & 
Cheema, 2014).  For example, when pregnant female rats were fed a diet either deficient 
or adequate in the n-3 PUFA ALA throughout gestation and lactation, the whole brain 
from male offspring obtained from the deficient mother had a decrease in the percentage 
of DHA, compared to male offsprings on a maternal diet adequate in ALA (Ozias et al., 
2007).  Similarly, when a maternal diet is deficient in n-3 PUFA during gestation and 
lactation, the adult male rats have a reduction in cerebral cortex DHA compared to adult 
male rats who were fed a maternal diet adequate in n-3 PUFA during this period (Garcia-
Calatayud et al., 2005).  Although the accumulation of DHA into the neuronal membrane 
is only rapid during brain growth and development, the accretion of DHA can also occur 
slowly in the adult brain (Moriguchi & Harauma, 2013).  The neuronal membrane PLs are 
continuously recycled in the adult brain, thus the PL fatty acid composition of the 
neuronal membrane has the propensity to change (Rapoport, 2001).  Plasma infusion 
studies using unesterfied radiolabelled DHA found adult male rats to replace 2-8% of 
esterified DHA daily (Rapoport, 2001).  Interestingly, many animal, epidemiological and 
clinical studies have shown that the risk of Alzheimer’s disease was reduced with a higher 
intake of DHA (Green et al. 2006; Luchtman & Song, 2013; Kiso, 2011).  Thus, DHA 
has the propensity to protect the brain during adult years.  
To date, no study has determined whether the effects of a diet high in n-3 PUFA 
will alter the fatty acid composition of various regions of the brain in an age and sex 
related manner.  Therefore, whether male or female brains have an alteration in the 
regulation n-3 PUFA metabolism as they age is unknown. 
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1.5 Mouse as an animal model  
The genetic background of a mouse is the most characterized out of all mammals  
(Paigen et al., 1990).  The mouse model has been the favourable model for animal 
experimentation because of its short reproduction period (Fazio & Linton, 2001).  We 
chose the C57BL/6N mouse for our study because it has been well established to 
investigate the effects of diet on neuronal and behaviour studies (Crawley et al., 1997).  
Furthermore, the C57BL/6N mouse has been used as the strain of choice to generate 
numerous transgenic models to study the pathological conditions of various 
neuropsychiatric illnesses (Flint, 2006).  Therefore, using this mouse model leaves our 
options open to extend our study with different neuropsychiatric transgenic mouse models 
in the future. 
1.6 Rationale   
Majority of the studies supporting beneficial effects of n-3 PUFA on the function 
of brain have focussed on the cortex.  Other regions of the brain also play important 
functions, however there is limited evidence on the effect of n-3 PUFA on other regions 
of the brain.  In addition, as most neuropsychiatric diseases have underlying age and sex-
specific risk factors, it is important to establish whether diets enriched in n-3 PUFA have 
similar effects on the fatty acid composition of different regions of the brain, and whether 
the effects are age and sex-specific.  It is also important to investigate whether altering the 
fatty acid composition of different regions of the brain alters the gene expression of 
neurotrophins and other genes regulating the myelin sheath formation.   
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1.6.1 Overall hypothesis  
The overall hypothesis for this thesis is that a diet high in n-3 PUFA will increase 
the accretion of DHA in the brainstem and cerebellum, leading to an increase in the 
mRNA expression of BDNF and genes related to myelin sheath formation.    
1.6.2 Specific aims  
Aim 1: To investigate the dose, age, and sex-specific effects of dietary n-3 PUFA on the 
accretion of phospholipid fatty acids in cerebellum and brainstem, and the regulation of 
mRNA expression of BDNF, TrkB and the genes involved in myelin sheath formation.    
Hypothesis: The prevalence of neuropsychiatric illnesses in females and males differ with 
age.  However, no study to date has investigated the importance of a diet high in n-3 
PUFA on the fatty acid composition, along with the mRNA expression of BDNF, TrkB 
and the genes involved in myelin sheath formation in a sex, age and region-specific 
manner.  It was hypothesized that the effects of a diet high in n-3 PUFA on the accretion 
of phospholipid fatty acids, and the mRNA expression of BDNF, TrkB and genes 
involved in myelin sheath formation will be age, sex and region-specific.  
Aim 2: To investigate whether prolonged exposure to diets high in n-3 PUFA will 
increase the accretion of DHA in adult cerebral cortex.  
Hypothesis: The fatty acid composition of the adult-brain is tightly regulated and is 
thought to be stable; however, it is not clear whether prolonged exposure to diets rich in 
n-3 PUFA can affect the accretion of DHA in an adult cerebral cortex.  It was 
hypothesized that a diet high in n-3 PUFA will increase the accretion of DHA in the 
cerebral cortex with longer exposure to the diet. 
Aim 3: To investigate the mechanisms by which n-3 PUFA regulate the cerebral cortex 
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mRNA expression of BDNF, TrkB and genes involved in myelin sheath formation using 
primary cortical cells.  
Hypothesis: The cerebral cortex is highly enriched in both DHA and AA that play an 
important role  in brain function mediated by neurotrophic factors.  However, it is not 
known whether DHA and AA have similar effects on the regulation of neurotrophic 
factors.  It was hypothesized that BDNF and TrkB will be regulated by DHA in cerebral 
cortical neurons, while AA will have no effect.  It was further hypothesized that SCD1 
and MBP will be regulated by DHA, while AA will have no effect.  
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Chapter 2: Materials and Methods   
2.1 Diets and animals  
  A former Master’s student Raniru Randunu and the Ph.D. student Kayode 
Balogun were responsible for the described animal feeding trials and tissue collections 
(Balogun 2015; Randunu 2012).  
2.2 Diets 
A high fat diet was prepared using a base fat-free semi-synthetic diet (MP 
Biomedicals, Santa Ana, CA, USA) designed to control for fat levels at 20% w/w.  The 
composition of the semi-synthetic base diet is given in Appendix 2.  Menhaden fish oil 
(Sigma-Aldrich, St. Louis, MO, USA), safflower oil, extra-virgin olive oil, and lard 
(purchased from local grocery stores) were used as sources of n-3 PUFA, n-6 PUFA, 
MUFA, and SFA, respectively.  These oils were used in specific combinations to make 
two different diet mixtures containing either 10% w/w (high n-3 PUFA) or 2% w/w (low 
n-3 PUFA) n-3 PUFA of the total dietary fat (Balogun & Cheema, 2014).  The 10% and 
2% w/w n-3 PUFA diets represent the suggested and the current North American intake 
of n-3 PUFA, respectively (Simopoulos, 2011; Kris-Etherton et al., 2000).  The amounts 
of total SFA, MUFA, and PUFA were kept constant; however, the amount of n-6 and n-3 
PUFA varied depending on the diet.  The fatty acid composition of the experimental diets 
was analyzed using gas chromatography (GC), and is given in Appendix 1.  The high-fat 
diets with different amounts of n-3 PUFA were stored at -20°C under nitrogen to prevent 
fatty acid oxidation.  
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2.3 To investigate the effects of perinatal and post-weaning diets high or low in n-3 
PUFA on different regions of the brain  
Male and female C57BL/6 N mice (seven weeks old) were purchased from 
Charles Rivers Laboratories (Wilmington, MA, USA).  The mice were housed in separate 
cages under controlled temperature (21 ± 1 °C) and humidity (35 ± 5%) conditions with a 
12 hour light/ 12 hour dark period cycle.  Mice were kept on a standard chow diet (Prolab 
RMH 3000; PMI nutrition, USA) for a one week acclimatization period.  Female mice 
were then randomly divided into two dietary groups, and fed diets high (10% w/w) or low 
(2% w/w) in n-3 PUFA for two weeks before mating. Male mice consumed  a standard 
chow diet, except during one-week of mating when they consumed the same diet as 
females.  Mice were continued on the experimental diets during mating, throughout 
gestation, lactation, and up until weaning (Figure 2.1).  At weaning, offspring from both 
experimental diet groups (male, n=8 and female, n=8) were fasted overnight for 12 hours 
then sacrificed using isoflurane as an anesthetizing agent and cardiac puncture.    In 
another study, the offspring from both experimental diet groups (male, n=8 and female, 
n=8) were continued on their mother’s diet for an additional 16 weeks post-weaning.  
Throughout the experimental period, the animals were provided water and fresh food ab 
libitum, which was replenished every other day.  Body weights were measured once a 
week, while food intake was recorded every other day.  Recorded food intake and body 
weight showed no significant differences between groups, as shown in a previous study 
(Balogun, 2015).  At the end of the experimental period, the animals were fasted 
overnight and anesthetized using isoflourane. These animals were also used by the former  
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Figure 2.1: Experimental design for feeding a diet high or low in n-3 PUFA to female 
C57BL/6N mice during gestation and lactation.  
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Ph.D. student Kayode, who undertook metabolic studies for which it was important to fast 
the animals.   The head was decapitated using large scissors and transferred to an ice-
chilled petri dish to dissect out the whole brain.  The whole brain was placed onto a 
separate ice-chilled petri dish to segregate the brainstem, cerebellum and cerebral cortex 
(Figure 2.2).  The brain regions were snap frozen in liquid nitrogen, and stored at -80°C 
until further use.  Experimental procedures were done in accordance with the principles 
and guidelines of the Canadian Council on Animal Care and were approved by Memorial 
University’s Animal Care Committee.   
2.4 To investigate the effects of diets high or low in n-3 PUFAs on adult C57BL/6N 
cerebral cortex 
Female C57BL/6 N mice (seven weeks old) were purchased from Charles River 
Laboratories and housed as explained in Section 2.3.   After one-week acclimatization 
period, female mice were randomly divided and placed on either a high (10% w/w) or a 
low (2% w/w) n-3 PUFA diet (Figure 2.3).  The specified diets were fed for either 4 
weeks or 8 weeks.  Animals were provided with deionized water and fresh food ad- 
libitum, which was replenished every other day.  Body weights were recorded once a 
week, while food intake was recorded every other day; diet had no effect on body weight 
or food intake (Randunu, 2012).  At the end of the treatment period,  mice were 
decapitated and brain sections were removed  as explained  in Section 2.3.  
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Figure 2.2: Dissection of whole mouse brain to isolate cerebral hemispheres, 
cerebellum, and brainstem.  
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Figure 2.3: Experimental design for feeding a diet high or low in n-3 PUFA to adult 
female C57BL/6N mice for 4 or 8 weeks.  
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2.5 Lipid extraction 
Total lipids were extracted from specific regions of the brain using the method of 
Folch et al. (1957).  PLs were then separated from total lipids using thin-layer 
chromatography (Keenan, 1982).  Total extracted lipids were dissolved in 100 μL of 
chloroform and spotted on 20 x 20 cm flexible plates coated with silica gel (Cat 
#:4420222, Whatman Ltd. UK).  PLs were separated using the solvent system: 
hexane:ethyl ether:acetic acid (70:30:20 v/v; Keenan, 1982).  PL spots were extracted 
using chloroform: methanol (2:1 v/v) and fatty acid methyl esters were prepared using the 
method of Arvidson and Olivecrona (1962).  Trans-methylation reagent (2 mL of 94% 
methanol, 6% of 98% sulfuric acid) was added to the extracted PLs along with a few 
crystals of the anti-oxidant hydroquinone for 2 hours at 65°C.  Methyl esters were 
extracted using hexane and water, then placed at -20°C overnight.  The supernatant was 
dried under nitrogen and re-suspended in carbon disulphide prior to GC analysis.  
Samples were run for 60 minutes on an Omega-wax X 320 (30 m x 0.32 mm) column 
from Supelco (Sigma-Aldrich) using a flame ionization detector.  The GC parameters 
were set as follows: oven temperature, 200°C; injector temperature, 240°C; and detector 
temperature 260°C.  The GC was ignited and allowed to run until the baseline was stable.  
PUFA standards -2 and -3 (Sigma-Aldrich) were used as standards for identification of 
fatty acids peaks by retention time. 
2.6 RNA extraction and real-time quantitative polymerase chain reaction  
2.6.1 Total RNA isolation  
  Total RNA was extracted from the cerebellum and brainstem tissues using the 
Trizol method (Invitrogen, Carlsbad, CA, USA) (Chomczynski & Sacchi, 1987).  
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Contaminating genomic DNA was removed by treating with RNase-free DNAse 1 
enzyme (Promega, Madison, WI, USA).  RNA concentration and purity was assessed 
using the Nano-drop spectrophotometer 2000 (Thermo Scientific, Waltham, MA, USA) 
and RNA integrity was checked using 1.2% agarose gel.  The synthesis of cDNA was 
carried out using the isolated RNA, random hexamer primers (0.5g/L; Promega) and a 
reverse-transcription master-mix [(5x Reverse Transcriptase buffer (Promega), 
recombinant RNAsin (Promega), M-MLV Transcriptase (Promega), and 10mM dNTPs 
(10 mM dATP, 10 mM dGTP, 10 mM dCTP and 10 mM dTTP; Invitrogen)].  The 
conditions and settings for cDNA synthesis were carried-out as described by Promega.  
Samples were then stored at -20°C.  
2.6.2 Real-time quantitative polymerase chain reaction  
 Real-time quantitative polymerase chain reaction (RT-qPCR) was performed 
using the iQ SYBR Green Supermix (Bio-Rad, Hercules, CA, USA) as described by the 
manufacturer.  All primers used for qPCR were designed using NCBI primer blast 
(www.ncbi.nlm.nih.gov/ tools/primer-blast/) and obtained from IDT Technologies 
(Coralville, IA, USA); primer sequences, amplicon sizes, and reaction efficiencies are 
given in Table 2.1.  The reactions were run at a total volume of 10 L with 25 ng cDNA 
per reaction.  Samples were run for 40 cycles (95°C for 15 seconds for denaturation, 58°C 
for 15 seconds for annealing and 72°C for 15 seconds for extension) using the CFX96TM 
Real-Time System.  No template controls were used for each gene  per experiment to 
ensure amplification was specific to the gene of interest.  Data output was managed using 
the CFX ManagerTM Software Version 3.0.  
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Table 2.1: Sequences and specifications of primers used for RT-qPCR 
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All primers were designed using NCBI primer blast and obtained from IDT technologies. Abbreviations: BDNF = brain-
derived neurotrophic factor; TrkB = tropomyosin-receptor kinase B; SCD1 = stearoyl-CoA desaturase-1; MBP = myelin 
basic protein; β – actin = beta-actin
Gene Forward Primer  
(5’-3’) 
Reverse Primer  
(5’-3’) 
Reference 
Sequence 
Amplicon 
Size  
Efficiency 
BDNF  tacttcggttgcatgaaggcg  gtcagacctctcgaacctgcc  NM_001316310.1 137 bp 100% 
TrkB  cggcacataaatttcacacg  ttacccgtcaggatcaggtc  XM_006517152 92 bp 100% 
SCD1 agagtagctgagctttgggc acaccccgacagcaatatccag NM_009127.4 105 bp 99% 
MBP  agagtccgacgagcttcaga caggtacttggatcgctgtg XM_006526452.2 106 bp 101% 
β – actin  cacgcagctcattgtagaagg atggtgggaatgggtcagaag NM_007393.5 157 bp 100% 
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Relative gene expression was normalized to -actin, then calculated and recorded using 
the comparative ΔΔCt method (Livak & Schmittgen, 2001).   
2.7 Primary cortical cell culture 
2.7.1 Preparation of Poly-L-Ornithine coated plates 
The cell culture plates were coated with poly-L-ornithine (PLO) to allow primary 
cortical cells adhesion to the surface.  A solution of PLO (Sigma-Aldrich) was prepared 
with autoclaved deionized water to a concentration of 10 mg/mL, filter sterilized using a 
0.22 μm sterile syringe filter and stored at -20°C until further use.  The stock solution of 
PLO was further diluted with autoclaved deionized water to a final concentration of 500 
μg/mL.  PLO (1 mL and 50 μL) was added to a 6 well and 96 well plate, respectively.  
Plates were kept in the laminar flow hood for 2 hours after plating; PLO was removed 
and the plates were allowed to dry completely.  This step was repeated once again, plates 
were then rinsed with autoclaved deionized water, allowed to dry and stored at 4°C until 
further use. 
2.7.2 Cortical cell culture 
 C57BL/6N mice pups (1-2 days old) were decapitated using sterilized large 
scissors and dissected using a procedure adapted from Nafar and Mearow (2014) and 
Vyas et al. (2013).  A dorsal incision from posterior to anterior was made to remove the 
skin from the head.  From the foramen magnum, the skull was cut laterally on both sides, 
then dorsally from posterior to anterior.  The skull was then pulled off and the brain was 
carefully removed, and placed in a petri dish containing 1x Hank’s Balanced Salt 
Solution (1xHBSS, Ca2+ and Mg2+ free; Life Technologies, Carlsbad, CA, USA) 
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supplemented with penicillin-streptomycin (pen-strep; 100 μg/mL; Life Technologies).  
Using a scalpel and 24 ½ gauge syringe needle, the cerebellum was removed followed by 
the separation of the two remaining cerebral hemispheres.  Using fine-tip tweezers, the 
corpus callosum and basal ganglia were then removed to isolate the cerebral cortex.  
Meninges and blood vessels were removed from both cerebral hemispheres, followed by 
teasing of the tissue using fine-tip tweezers.  Cerebral hemispheres were placed into a 15 
mL conical tube containing 1x HBSS supplemented with pen-strep on ice.   
Cortical tissue was allowed to settle at the bottom of the 15 mL tube and the 
supernatant was aspirated.  Fresh 1x HBSS supplemented with pen-strep was added to the 
cortical tissue; the cells were allowed to settle to the bottom of the tube and the the 
supernatant was aspirated.  Fresh 1xHBSS supplemented with pen-strep, Mg2+ (0.49 
mM), Ca2+ (1.26 mM), Trypsin-EDTA (0.01%; Life Technologies), and DNAse (5 
mg/mL; Sigma) was added to the cortical cells and incubated at 37°C for 20 minutes.  
The cells were allowed to settle and the trypsin containing supernatant was aspirated and 
replaced with Basal Medium Eagle growth medium (Life Technologies) containing 10% 
horse serum (Life Technologies), an antibiotic− antimycotic solution (100 units/mL 
penicillin G, 100 μg/mL streptomycin sulphate and 250 ng/mL amphotericin B; Life 
Technologies), 0.5% glucose (Sigma), 1 mM sodium pyruvate (Life Technologies) and 
1% N2 supplements (Life Technologies)] for 10 minutes to inhibit trypsin (Life 
Technologies).  The medium was aspirated and replaced with fresh growth medium.  The 
tissue was then triturated using a flame molded Pasteur pipette until a homogenous 
cellular solution was obtained.  Cells were counted using a haemocytometer and plated to 
a concentration of 2.0x106 cells/mL.  After two hours, the medium was completely 
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removed and replaced with fresh growth medium containing serum.  After 48 hours, half 
of the medium was removed and replaced with fresh serum-free Basal Medium Eagle 
culture medium [(Life Technologies) containing an antibiotic− antimycotic solution (100 
units/mL penicillin G, 100 μg/mL streptomycin sulphate, and 250 ng/mL amphotericin B; 
Sigma), 0.5% glucose (Sigma), 1 mM sodium pyruvate (Invitrogen), 2 mM Glutamine 
(Sigma) and 2% B27 supplements (Invitrogen)].  Only half of the culture medium was 
changed every 2 days with fresh culture medium due to the fragile nature of neuronal 
cells.  Cells were checked daily and used on day 10 in vitro (DIV).   
2.7.3 Fatty acid treatments 
 Fatty acid treatments were prepared by conjugating specific fatty acids with fatty 
acid free bovine serum albumin (BSA) (Vaidya & Cheema, 2015).  Briefly, a 2% BSA 
solution was prepared using serum-free culture medium as described in section 2.7.2.  
DHA and AA were dissolved in 100% ethanol (100 mM) and mixed with 2% BSA 
solution to a final concentration of 2.5 mM for each fatty acid.  Prepared fatty acids were 
filter sterilized using a 0.22 μm sterile syringe filter and stored at 4°C. 
2.7.4 Cell viability assay  
 Cortical cells were cultured in a PLO pre-coated 96-well plate.  At DIV 10, the 
cells were treated with DHA (10, 25, 50, 75, 100, 250 and 500 μM) for 24 hours in an 
incubator at 37°C/5% CO2.  Ethanol was used as a vehicle control at a final concentration 
of 0.02%.  After the treatment period, the cells were incubated with 10% MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Sigma) for 4 hours at 37 °C/5% 
CO2.  The MTT solution was aspirated and the remaining formazan crystals were re-
suspended in 0.4 N HCl/isopropanol and shaken in the Fisher Brand Tempmaster for 3 
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minutes at room temperature.  The assay was read in the Biotek Power Wave XS using a 
wavelength of 570 nm.  Data were expressed as a percent of MTT activity in control 
cells.    
2.7.5 Fatty acid treatment of cortical cells to measure fatty acid analysis and gene 
regulation   
 Cortical cells were cultured in PLO pre-coated 6-well plates.  At DIV 10, the cells 
were treated with DHA (10, 25, 50, 75, and 100 μM) for 24 hours in an incubator at 
37°C/5% CO2.  Ethanol was used as a vehicle control at a final concentration of 0.02% 
corresponding to the highest amount of ethanol used in fatty acid treatments.  After the 
treatment period, the medium was removed and the cells were washed twice with ice-cold 
1xPBS (pH 7.4) and scraped in 1xPBS (pH 7.4).  The cellular suspension was aliquoted 
into a 1.5 mL Eppendorf tube and spun at 3000 rpm for 5 minutes at 4°C to sediment the 
cells, the supernatant was removed and the cells were re-suspended in 300 μL of 50 mM 
NaCl.  Lipids were extracted and trans-methylated as described in methods section 2.5.   
Cortical cells were cultured in PLO pre-coated 6-well plates.  At DIV 10, the cells 
were treated with 50 μM of either DHA or AA for 24 hours in an incubator at 37°C/5% 
CO2.  Ethanol was used as a vehicle control at a final concentration of 0.01%, which 
represented the percentage of ethanol in the 50 μM DHA and AA treatments.  After the 
treatment period, the medium was removed and the cells were washed twice with ice-cold 
1xPBS (pH 7.4).  One mL of Trizol Reagent was added to the wells and cells were 
scraped.  RNA extraction, cDNA synthesis and RT- qPCR was performed as described in 
methods section 2.6.  The RT-qPCR reactions were run at a total volume of 10 L with 
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100 ng cDNA per reaction.  Relative gene expression was calculated using the published 
comparative ΔΔCt method (Livak & Schmittgen, 2001).  The Ct value of the target gene 
is normalized to that of the reference gene (-actin), and the change in Ct is normalized to 
a change in Ct of a chosen calibrator sample.  Data were expressed as relative to the gene 
expression of -actin.    
2.8 Statistical analysis 
 Data were analyzed using IBM SPSS Statistics version 21.0.  For all in vivo 
studies, means were compared using three-way analysis of variance (ANOVA) to 
determine the main effects of diet, age and sex.  Pairwise comparisons were conducted 
using Bonferroni correction to determine differences among the groups only when there 
was an observed interaction between sex and diet, sex and age, diet and age, and sex, diet, 
and age.  Results were expressed as mean ± standard deviation (SD). 
For all in vitro experiments (cell culture studies) one way ANOVA was used to 
compare the differences between control and treatment groups.  Significant effects were 
further analyzed using Bonferroni multiple comparisons post-hoc statistical tests.  Fatty 
acid compositions were expressed as relative weight percentage of the total extracted 
fatty acids; fatty acid composition data were then arcsine transformed before subjecting 
to statistical analysis to normalize data.  For all statistical analysis, differences were 
considered to be statistically significant if the associated P value was <0.05. 
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Chapter 3: Results 
 
3.1 Effects of a diet high or low in n-3 PUFA on the phospholipid fatty acid 
composition of the cerebellum 
The cerebellum PL SFA composition of the offspring, obtained from mothers fed 
a diet high or low in n-3 PUFA, at weaning and 16 weeks postweaning is given in Table 
3.1.  There was no independent effect of the diet for total or individual SFA amongst the 
two dietary groups.  However, a significant interaction was observed between sex and age 
in total PL SFA and individual SFA (P<0.05).  Interestingly, there was an age dependent 
decrease in the percentage of total SFA in the female offspring cerebellum (P<0.05); 
however, this effect was not observed in the male offspring.  There was a decrease in 
C14:0 and C16:0 from weaning to 16 weeks in both males and females (P<0.05).  
Females at weaning had a higher percentage of C16:0 and C18:0 compared to the males 
(P<0.05).  
The cerebellum PL MUFA composition of the offspring, obtained from mothers 
fed a diet high or low in n-3 PUFA at weaning and 16 weeks postweaning, is given in 
Table 3.2.  There was a significant interaction between sex and age for C16:1n-7 
(P<0.0001), while there was no independent effect of the diet.  At weaning, male 
offspring had a higher percentage of C16:1n-7 compared to the female offspring 
(P<0.05); however, this difference disappeared at 16 weeks.  It was interesting to note 
that the male offspring had an age dependent decrease in C16:1n-7 from weaning to 16 
weeks (P<0.05), while this effect was not observed in the females.  Furthermore, there  
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Table 3.1: Effects of a diet high or low in n-3 PUFA on the phospholipid saturated 
fatty acid composition of the cerebellum from male and female offspring at weaning 
and 16 weeks postweaning 
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Data are expressed as weight percentage of the total extracted phospholipid fatty acids. Mean  SD, n=8.  Main effects and 
interactions were determined by three-way ANOVA; pairwise comparisons using Bonferroni correction was used to determine 
differences when there was an observed statistical significant interaction.  Within a column, statistically significant values are 
marked with unlike superscripts when a significant interaction was observed (P<0.05) between sex and age (a,b,c).  NS= non-
significant; ΣSFA = sum of saturated fatty acids.     
 SFA (%w/w) 
                
        C14:0 C16:0 C18:0 ΣSFA 
Male    Weaning High n-3  0.65 ± 0.09a 24.30 ± 1.33b 22.23 ± 1.96b 47.19 ± 3.03b 
      Low n-3  0.63 ± 0.06a 22.87 ± 1.01b 23.29 ± 1.82b 46.80 ± 2.08b 
                
    16 Weeks High n-3  0.26 ± 0.06b 21.42 ± 1.32c 23.54 ± 1.48b 45.22 ± 2.73b 
      Low n-3  0.40 ± 0.16b 20.94 ± 1.72c 23.91 ± 1.41b 45.25 ± 2.93b 
                
Female    Weaning High n-3  0.78 ± 0.14a 26.35 ± 1.73a 26.33 ± 2.02a 53.47 ± 3.47a 
      Low n-3  0.74 ± 0.11a 26.26 ± 1.81a 25.04 ± 0.93a 52.05 ± 2.43a 
                
    16 Weeks  High n-3  0.29 ± 0.05b 21.11 ± 0.89c 23.82 ± 0.61ab 45.23 ± 1.43b 
      Low n-3  0.28 ± 0.14b 21.55 ± 1.52c 25.94 ± 1.94ab 47.78 ± 3.27b 
                
Sex       NS P < 0.001 P < 0.0001 P < 0.0001 
Diet       NS NS NS NS 
Age       P < 0.0001 P < 0.0001  NS P < 0.0001 
Sex*Diet     NS NS NS NS 
Sex*Age     P < 0.05 P < 0.01 P < 0.05 P < 0.05 
Diet*Age     NS NS NS NS 
Sex*Diet*Age   NS NS P < 0.05 NS 
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Table 3.2: Effects of a diet high or low in n-3 PUFA on the phospholipid monounsaturated 
fatty acid composition of the cerebellum from male and female offspring at weaning and 16 
weeks postweaning 
 ͸Ͳ 
Data are expressed as weight percentage of the total extracted phospholipid fatty acids. Mean  SD, n=8.  Main effects and        
interactions were determined by three-way ANOVA; pairwise comparisons using Bonferroni correction was used to determine 
differences when there was an observed statistical significant interaction.  Within a column, statistically significant values are 
marked with unlike superscripts when a significant interaction was observed (P<0.05) between sex and age (a,b ,c) and diet and 
age (A,B).  NS= non-significant; ΣMUFA = sum of monounsaturated fatty acid. 
MUFA (%w/w) 
                
   
C16:1n-7 C18:1 C20:1n-9 ΣMUFA 
Male  Weaning High n-3 1.52 ± 1.01a 20.31± 0.94B 1.44 ± 0.57 23.27 ± 1.97 
  
Low n-3 0.96 ± 0.07a 21.49 ± 1.36B 2.26 ± 0.64 24.71 ± 1.96 
       
  
16 Weeks High n-3 0.50 ± 0.04c 26.75 ± 1.32A 3.91 ± 0.81 31.15 ± 1.96 
  
Low n-3  0.53 ± 0.15c 24.99 ± 1.51A 4.16 ± 0.94 29.68 ± 2.38 
       Female  Weaning High n-3 0.77 ± 0.11b 20.85 ± 3.35B 1.26 ± 0.90 22.88 ± 4.32 
  
Low n-3  0.76 ± 0.19b 21.58 ± 1.56B 1.62 ± 0.57 23.97 ± 2.12 
       
  
16 Weeks High n-3  0.64 ± 0.13bc 26.08 ± 1.16A 3.51 ± 0.60 30.22 ± 1.64 
  
Low n-3  0.60 ± 0.20bc 24.85 ± 2.45A 3.87 ± 1.27 29.32 ± 3.67 
       Sex 
  
NS NS NS NS 
Diet 
  
NS NS P<0.05 NS 
Age 
  
P < 0.0001 P < 0.0001 P < 0.0001 P<0.0001 
Sex*Diet 
 
NS NS NS NS 
Sex*Age 
 
P < 0.0001 NS NS NS 
Diet*Age 
 
NS P < 0.05 NS NS 
Sex*Diet*Age   NS NS NS NS 
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was a significant interaction between age and diet for C18:1 (P<0.05), with no significant 
independent effect of diet.  Interestingly, C18:1 and C20:1n-9 increased from weaning to 
16 weeks (P<0.0001) in both males and females.  There was also an independent effect of 
the diet, where both male and the female offspring fed a diet high in n-3 PUFA showed 
higher percentage of C20:1n-9 compared to the low n-3 PUFA group (P<0.05).  Finally, 
the cerebellum from both male and female offspring revealed approximately 7% increase 
in total MUFA from weaning to 16 weeks (P<0.0001).  
The cerebellum PL n-6 PUFA composition of the offspring, obtained from 
mothers fed a diet high or low in n-3 PUFA, at weaning and 16 weeks postweaning is 
given in Table 3.3.  Diet had no significant effect on total n-6 PUFA at weaning in both 
male and the female offspring.  However, there was a decrease in LA and total n-6 PUFA 
from weaning to 16 weeks, and the effect was more pronounced in mice fed a diet high in 
n-3 PUFA compared to the low n-3 PUFA group at 16 weeks (P<0.0001).  A reduction in 
LA was seen in the male and female offspring fed a diet high in n-3 PUFA, compared to 
the low n-3 PUFA diet group.  There was an independent effect of age and diet on adrenic 
acid (ADA; C22:4n-6), with ADA decreasing from weaning to 16 weeks (P<0.0001); 
there was a lower percentage in the male and female offspring fed a diet high in n-3 
PUFA compared to the low n-3 PUFA group (P<0.0001).  Perinatal and postweaning 
exposure to a diet high in n-3 PUFA led to a decrease in AA in the male and female 
cerebellum both at weaning and 16 weeks, compared to mice fed the low n-3 PUFA diet 
(P<0.0001).  There was also a significant interaction between age and sex on AA in the 
cerebellum (P<0.005).  At weaning, male offspring had a higher percentage of AA 
compared to the females (P<0.05) but the effect of sex was not observed at 16 weeks.   
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Table 3.3: Effects of a diet high or low in n-3 PUFA on the phospholipid n-6 
polyunsaturated fatty acid composition of the cerebellum from male and female 
offspring at weaning and 16 weeks postweaning 
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Data are expressed as weight percentage of the total extracted phospholipid fatty acids. Mean  SD, n=8.  Main effects and 
interactions were determined by three-way ANOVA; pairwise comparisons using Bonferroni correction was used to determine 
differences when there was an observed statistical significant interaction.  Within a column, statistically significant values are 
marked with unlike superscripts when a significant interaction was observed (P<0.05) between sex and age (a,b ,c) and diet and 
age (A,B,C).  LA = linoleic acid; AA = arachidonic acid; ADA = adrenic acid; NS= non-significant; Σn-6 PUFA = sum of 
omega-6 polyunsaturated fatty acids.  
N-6 PUFA (%w/w) 
       
    
C18:2n-6 (LA) C20:4n-6 (AA) C22:4n-6 (ADA)  Σn-6PUFA 
Male  Weaning High n-3  2.31 ± 0.48Aa 9.49 ± 0.64a 1.97 ± 0.52 13.77 ± 0.90Aa 
  
Low n-3  1.96 ± 0.21Aa 10.63 ± 1.06a 2.52 ± 0.29 15.12 ± 1.04Aa 
       
  
16 Weeks High n-3  0.99 ± 0.24Cc 5.44 ± 0.71c 1.04 ± 0.28 7.47 ± 1.06Cc 
  
Low n-3  1.26 ± 0.21Bc 6.87 ± 0.52c 2.17 ± 0.88 10.29 ± 1.30Bc 
       Female  Weaning High n-3  1.81 ± 0.18Ab 8.12 ± 0.94b 1.47 ± 0.26 11.39 ± 1.02Ab 
  
Low n-3  1.57 ± 0.22Ab 9.23 ± 0.72b 2.13 ± 0.57 12.93 ± 0.89Ab 
       
  
16 Weeks High n-3  1.00 ± 0.42Cc 5.56 ± 0.49c 1.29 ± 0.64 7.86 ± 1.10Cc 
  
Low n-3  1.35 ± 0.25Bc 6.64 ± 1.05c 1.72 ± 0.31 9.71 ± 1.18Bc 
       Sex 
  
P < 0.05 P < 0.005 NS P < 0.0001 
Diet  
  
NS P < 0.0001 P < 0.0001 P < 0.0001 
Age 
  
P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001 
Sex*Diet 
  
NS NS NS NS 
Sex*Age 
  
P < 0.01 P < 0.005 NS P < 0.001 
Diet*Age 
 
P < 0.0001 NS NS P < 0.05 
Sex*Diet*Age   NS NS NS NS 
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There was also a significant effect of age on cerebellar AA, which revealed a decrease in 
AA in both male and female offspring, respectively, from weaning to 16 weeks (P<0.05).  
The cerebellum PL n-3 PUFA composition of the offspring, obtained from 
mothers fed a diet high or low in n-3 PUFA, at weaning and 16 weeks postweaning is 
given in Table 3.4.  We were unable to detect and quantify ALA, EPA and C22:5n-3, 
likely due to very low concentrations of these  fatty acids.  The only n-3 PUFA detected 
in the cerebellum was DHA, which exhibited a significant interaction between sex, diet, 
and age (P<0.05).  The driving factor for the three-way interaction is sex, as sex is driving 
a difference between DHA accretion between male and female offspring.  A diet high in 
n-3 PUFA caused an increase in DHA at weaning and 16 weeks in both males and 
females (P<0.0001).  Interestingly, at weaning, females had lower levels of DHA 
compared to the males.  However, the amount of DHA increased from weaning to 16 
weeks in the females (P<0.05).  There was no significant effect of sex on DHA at 16 
weeks.  
3.2 Effect of a diet high or low in n-3 PUFA on the mRNA expression of BDNF 
and TrkB of the cerebellum 
 The effects of a perinatal and postweaning diet high or low in n-3 PUFA on 
cerebellar mRNA expressions of BDNF and TrkB were assessed using real-time qPCR 
analyses.  There was an independent significant effect of age (P<0.0001) (Figure 3.1A) on 
the mRNA expression of BDNF.  The mRNA expression of BDNF increased from 
weaning to 16 weeks postweaning in both the female and male offspring (P<0.0001)  
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Table 3.4: Effects of a diet high or low in n-3 PUFA on the phospholipid n-3 
polyunsaturated fatty acid composition of the cerebellum from male and female 
offspring at weaning and 16 weeks postweaning 
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Data are expressed as weight percentage of the total extracted phospholipid fatty acids. Mean  SD, n=8.  Main effects and 
interactions were determined by three-way ANOVA; pairwise comparisons using Bonferroni correction was used to determine 
differences when there was an observed statistical significant interaction.  Within a column, statistically significant values are 
marked with unlike superscripts when a significant interaction was observed (P<0.05) between sex and age (a,b).  ALA = alpha-
linolenic acid; EPA = eicosapentaenoic acid; DHA = docosahexaenoic acid; NS = non-significant; ND = not detected.  
 N-3 PUFA (%w/w) 
         
    C18:3n-3 (ALA) C20:5n-3 (EPA) C22:5n-3 C22:6n-3 (DHA) 
Male   Weaning High n-3  ND ND ND 15.78 ± 1.27a 
   Low n-3  ND ND ND 13.38 ± 1.86a 
          16 Weeks High n-3  ND ND ND 16.15 ± 2.56a 
   Low n-3  ND ND ND 14.78 ± 1.48a 
        Female   Weaning High n-3  ND ND ND 12.26 ± 1.47b 
   Low n-3  ND ND ND 11.05 ± 0.56b 
          16 Weeks High n-3  ND ND ND 16.57 ± 1.01a 
   Low n-3  ND ND ND 13.19 ± 2.56a 
        
Sex       P < 0.0001 
Diet        P < 0.0001 
Age       P < 0.0001 
Sex*Diet       NS 
Sex*Age       P < 0.001 
Diet*Age      NS 
Sex*Diet*Age         P < 0.05 
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Figure 3.1: Effects of a diet high or low in n-3 PUFA on the mRNA expression of 
brain-derived neurotrophic factor and tropomyosin-receptor kinase B of the 
cerebellum:  Data represents female and male cerebellar mRNA expression of brain-
derived neurotrophic factor (BDNF) (A) and tropomyosin-receptor kinase B (TrkB) (B) at 
weaning and 16 weeks, normalized to -actin as the house-keeping gene.  Main effects 
and interactions were determined by three-way ANOVA; pairwise comparisons using 
Bonferroni correction was used to determine differences when there was an observed 
statistical significant interaction.  Mean (n=8)  SD.  NS = non-significant.     
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(Figure 3.1A).  There was a trend towards higher mRNA expression of BDNF in the 
females, compared to the males (P=0.068) (Figure 3.1A).   
There was no effect of diet on TrkB mRNA expression (Figure 3.1B), however, 
there was a significant effect of age (P<0.05) and sex (P<0.05) (Figure 3.1B).  There was 
a decrease in the mRNA expression of TrkB in both male and female offspring from 
weaning to 16 weeks, (P<.0.05) (Figure 3.1B); however, males had a higher cerebellar 
TrkB mRNA expression compared to females, at both weaning and 16 weeks (P<0.05) 
(Figure 3.1B).  
3.3 Effect of a diet high or low in n-3 PUFA on the mRNA expression of SCD1 and 
MBP of the cerebellum 
 The effects of a perinatal and postweaning diet high or low in n-3 PUFA on 
cerebellar myelin sheath formation related genes (SCD1 and MBP) was assessed using 
real-time qPCR analysis.  There was an independent effect of diet on the mRNA 
expression of SCD1 (P<0.05) (Figure 3.2A).  A diet high in n-3 PUFA significantly 
increased the mRNA expression of SCD1 compared to the low n-3 PUFA diet (P<0.05) 
(Figure 3.2A).  There was a significant interaction between age and sex on the mRNA 
expression of SCD1 (P<0.05) (Figure 3.2A); female mice had an increase in the mRNA 
expression of SCD1 from weaning to 16 weeks (P<0.05); however, this effect of age was 
not observed in the male offspring.  A significant interaction was observed between sex, 
age, and diet on the mRNA expression of MBP (P<0.05) (Figure 3.2B).  Moreover, the 
effect of diet on the mRNA expression of MBP was sex and age dependent in both male  
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Figure 3.2: Effects of a diet high or low in n-3 PUFA on the mRNA expression of 
stearoyl-CoA desaturase-1 and myelin basic protein  in the cerebellum:  Data 
represents female and male cerebellar mRNA expression of stearoyl-CoA desaturase-1 
(SCD1) (A) and myelin basic protein (MBP) (B) at weaning and 16 weeks, normalized 
with -actin as the house-keeping gene.  Main effects and interactions were determined 
by three-way ANOVA; pairwise comparisons using Bonferroni correction was used to 
determine differences when there was an observed statistical significant interaction.  
Statistically significant values are marked with unlike letters (a,b,c) when a significant 
interaction was observed (P<0.05) between age and sex.  Mean (n=8)  SD.  NS = non-
significant. 
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and female cerebellums at weaning and 16 weeks (P<0.05) (Figure 3.2B).  There was also 
a significant interaction between age and diet (P<0.05) (Figure 3.2B).  Females fed a diet 
high in n-3 PUFA revealed an increase in MBP mRNA expression from weaning to 16 
weeks, compared to females fed a low n-3 PUFA diet (P<0.05) (Figure 3.2B).  On the 
other hand, male offspring fed a diet high in n-3 PUFA showed higher MBP mRNA 
expression compared to males fed a low n-3 PUFA diet at weaning (P<0.05) (Figure 
3.2B), while no effect of the diet was observed at 16 weeks. 
3.4 Effects of a diet high or low in n-3 PUFA on the phospholipid fatty acid 
composition of the brainstem 
 The brainstem PL SFA composition of the offspring, obtained from mothers fed a 
diet high or low in n-3 PUFA, at weaning and 16 weeks postweaning is given in Table 
3.5.  There was a significant independent effect of diet on total SFA and C14:0 (P<0.05).  
The high n-3 PUFA diet group showed an increase in the percentage of cerebellar PL 
C14:0 and total SFA in the male and female offspring, compared to low n-3 PUFA diet 
group (P<0.05).  Interestingly, there was a significant interaction observed between sex 
and age for C14:0, C16:0, C18:0, and total SFA (P<0.05).  At weaning, female offspring 
had a higher percentage of individual and total SFA compared to male (P<0.05); 
however, both female and male offspring had a decrease in the percentage of individual 
and total SFA from weaning to 16 weeks (P<0.05).  Moreover, the effect of sex 
disappeared at 16 weeks, where male and female offspring had similar percentages of 
individual and total SFA.  Finally, there was an observed interaction between age and diet  
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Table 3.5: Effects of a diet high or low in n-3 PUFA on the phospholipid saturated fatty 
acid composition of the brainstem from male and female offspring at weaning and 16 
weeks postweaning 
 ͹Ͷ 
Data are expressed as weight percentage of the total extracted phospholipid fatty acids. Mean  SD, n=8.  Main effects and 
interactions were determined by three-way ANOVA; pairwise comparisons using Bonferroni correction was used to determine 
differences when there was an observed statistical significant interaction.  Within a column, statistically significant values are 
marked with unlike superscripts when a significant interaction was observed (P<0.05) between sex and age (a,b ,c) and diet and 
age (A,B,C).  NS= non-significant; ΣSFA = sum of saturated fatty acids. 
SFA (%w/w) 
            C14:0 C16:0 C18:0 ΣSFA 
Male   Weaning High n-3  0.61 ± 0.06b 22.87 ± 1.02Ab 23.25 ± 1.89b 46.73 ±  2.77b 
   Low n-3  0.55 ± 0.13b 20.42 ± 0.89Bb 22.67 ± 1.26b 43.64 ± 1.88b 
    
      16 Weeks High n-3  0.36 ± 0.11c 18.12 ± 1.70Cc 21.70 ± 0.80c 40.18 ± 1.98c 
   Low n-3  0.29 ± 0.05c 18.23 ± 1.38Cc 22.09 ± 1.13c 40.61 ± 2.44c 
    
    Female  Weaning High n-3  0.81 ± 0.11a 26.91 ± 1.71Aa 26.82 ± 1.44a 54.54 ± 3.07a 
   Low n-3  0.76 ± 0.09a 25.07 ± 1.30Ba 26.90 ± 1.52a 52.73 ± 2.55a 
    
      16 Weeks High n-3  0.38 ± 0.20c 18.94 ± 1.03Cc 23.70 ± 4.94c 43.02 ± 4.45c 
   Low n-3  0.22 ± 0.08c 18.64 ± 0.81Cc 22.49 ± 0.48c 41.36 ± 1.06c 
    
    Sex    P < 0.05 P < 0.0001  P < 0.0001  P < 0.0001  
Diet     P < 0.005 P < 0.005 NS P < 0.05 
Age    P < 0.0001  P < 0.0001  P < 0.0001  P < 0.0001  
Sex*Diet   NS NS NS NS 
Sex*Age   P < 0.0001  P < 0.0001  P < 0.05 P < 0.05 
Diet*Age   NS P < 0.05 NS NS 
Sex*Diet*Age   NS NS NS  NS 
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on C16:0 (P<0.05).  At weaning, both male and female offspring fed a diet high in n-3 
PUFA had an increase in C16:0, compared to the low n-3 PUFA diet group (P<0.05). 
The brainstem PL MUFA composition of the offspring, obtained from mothers fed 
a diet high or low in n-3 PUFA, at weaning and 16 weeks postweaning is given in Table 
3.6.  There was a significant independent effect of sex (P<0.05) and age (P<0.001) on 
C20:1n-9.  Male offspring had a higher percentage of C20:1n-9 than females (P<0.05); 
however, both male and female offspring had a decrease in C20:1n-9 from weaning to 16 
weeks (P<0.0001).  There was a significant interaction between diet and age on brainstem 
PL C16:1n-7 (P<0.05).  Interestingly, male and female offspring fed a diet high in n-3 
PUFA showed higher levels of C16:1n-7 (P<0.05), compared to the low n-3 PUFA diet at 
weaning.  Finally, brainstem PL C18:1 and total MUFA in both male and female 
offspring increased from weaning to 16 weeks (P<0.0001).  
 The brainstem PL n-6 PUFA composition of the offspring, obtained from mothers 
fed a diet high or low in n-3 PUFA, at weaning and 16 weeks postweaning is given in 
Table 3.7.  There was a significant interaction between sex and age (P<0.05), and diet 
and age (P<0.0001) for brainstem PL LA and AA.  At weaning, diet had no effect on the 
male and female offspring LA and AA; however, there was a decrease in LA and AA in 
the offspring fed a high n-3 PUFA diet, compared to the low n-3 PUFA group (P<0.05).  
In addition, there was an observed effect of sex (P< 0.0001), with male offspring having a 
higher percentage of AA than females at weaning; however this effect disappeared at 16 
weeks.  There was a significant independent effect of diet (P<0.0001) on ADA, where a 
diet high in n-3 PUFA showed lower levels of ADA compared to the low n-3 PUFA diet.  
Total n-6 PUFA revealed a significant interaction between diet and age (P<0.01), again  
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Table 3.6: Effects of a diet high or low in n-3 PUFA on the phospholipid 
monounsaturated fatty acid composition of the brainstem from male and female 
offspring at weaning and 16 weeks postweaning 
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Data are expressed as weight percentage of the total extracted phospholipid fatty acids. Mean  SD, n=8.  Main effects and        
interactions were determined by three-way ANOVA; pairwise comparisons using Bonferroni correction was used to determine 
differences when there was an observed statistical significant interaction.  Within a column, statistically significant values are 
marked with unlike superscripts when a significant interaction was observed (P<0.05) between sex and age (a,b) and diet and 
age (A,B,C).  NS= non-significant; ΣMUFA = sum of monounsaturated fatty acid.  
MUFA (%w/w) 
        C16:1n-7 C18:1 C20:1n-9 ΣMUFA Male   Weaning High n-3  1.16 ± 0.09Aa 22.02 ± 2.30B 2.79 ± 0.76 25.97 ± 3.01B 
   Low n-3  0.93 ± 0.29Ba 24.46 ± 2.17B 3.12 ± 1.20 28.51 ± 3.41B 
    
      16 Weeks High n-3  0.68 ± 0.14Bb 32.69 ± 1.59A 7.60 ± 0.73 40.97 ± 2.11A 
   Low n-3  0.65 ± 0.14BCb 29.85 ± 1.67A 6.78 ± 1.31 37.27 ± 2.85A 
    
    Female  Weaning High n-3  0.84 ± 0.10Ab 22.79 ± 3.32B 1.94 ± 0.84 25.57 ± 4.17B 
   Low n-3  0.65± 0.09Bb 22.91 ± 2.26B 2.86 ± 0.97 25.57 ± 4.17B 
    
      16 Weeks High n-3  0.63 ± 0.09Bb 30.15 ± 2.51A 6.57 ± 1.11 37.36 ± 3.55A 
   Low n-3  0.59 ± 0.10BCb 30.48 ± 1.60A 6.66 ± 1.22 37.36 ± 3.55A 
    
    Sex    P < 0.0001 NS P < 0.05 NS 
Diet     P < 0.005 NS NS NS 
Age    P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001 
Sex*Diet   NS NS NS NS 
Sex*Age   P < 0.005 NS NS NS 
Diet*Age   P < 0.05 P < 0.05 NS P < 0.05 
Sex*Diet*Age   NS P  < 0.05 NS NS 
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Table 3.7: Effects of a diet high or low in n-3 PUFA on the phospholipid n-6 
polyunsaturated fatty acid composition of the brainstem from male and female 
offspring at weaning and 16 weeks postweaning 
 
 ͹ͻ 
Data are expressed as weight percentage of the total extracted phospholipid fatty acids.  Mean  SD, n=8.  Main effects and 
interactions were determined by three-way ANOVA; pairwise comparisons using Bonferroni correction was used to determine 
differences when there was an observed statistical significant interaction.  Within a column, statistically significant values are 
marked with unlike superscripts when a significant interaction was observed (P<0.05) between sex and age (a,b ,c,d) and diet 
and age (A,B,C).  LA = linoleic acid; AA = arachidonic acid; ADA = adrenic acid; NS= non-significant; Σn-6 PUFA = sum of 
n-6 polyunsaturated fatty acids.
N-6 PUFA (% w/w) 
       
    
C18:2n-6 (LA) C20:4n-6 (AA) C22:4n-6 (ADA) Σn-6PUFA 
Male   Weaning High n-3  1.63 ± 0.20Aa 8.48 ± 1.33Aa 2.44 ± 0.60a 12.55 ± 1.60ACa 
   Low n-3  1.63 ± 0.20Aa 9.34 ± 0.89Aa 3.84 ± 0.33a 14.72 ± 0.59Aa 
    
      16 Weeks High n-3  0.73 ± 0.14Cb 4.71 ± 0.71Cb 2.34 ± 0.59a 7.78 ± 1.13Ccbd 
   Low n-3  0.97 ± 0.16Bb 6.34 ± 0.65Bb 3.17 ± 0.79a 10.48 ± 1.15Bcbd 
    
    Female  Weaning High n-3  1.44 ± 0.19Aa 6.97 ± 1.23Ac 1.64 ± 0.29b 10.05 ± 1.29Abc 
   Low n-3  1.31 ± 0.18Aa 7.10 ± 0.75Ac 2.42 ± 0.29b 10.83 ± 0.84Ab 
    
      16 Weeks High n-3  0.72 ± 0.12Cb 4.80 ± 0.47Cb 2.12 ± 0.52ab 7.64 ± 0.56Cd 
   Low n-3  1.08 ± 0.20Bb 6.31 ± 0.51Bb 2.94 ± 0.33ab 10.33 ± 0.65Bd 
    
    Sex    NS P < 0.0001 P < 0.0001 P < 0.0001 
Diet     P < 0.05 P < 0.0001 P < 0.0001 P < 0.0001 
Age    P < 0.0001 P < 0.0001 NS P < 0.0001 
Sex*Diet   NS NS NS NS 
Sex*Age   P < 0.05 P < 0.0001 P < 0.005 P < 0.0001 
Diet*Age   P < 0.0001 P < 0.01 NS P < 0.01 
Sex*Diet*Age   NS NS NS NS 
 ͺͲ 
showing that offspring fed a diet high in n-3 PUFA had significantly lower amount of 
total n-6 PUFA compared to the low n-3 PUFA diet group at 16 weeks. 
 The brainstem PL n-3 PUFA composition of the offspring, obtained from mothers 
fed a diet high or low in n-3 PUFA, at weaning and 16 weeks postweaning is given in 
Table 3.8.  In both male and female offspring, the n-3 PUFA ALA, EPA and C22:5n-3 
were not detected in brainstem PL at weaning and 16 weeks.  Interestingly, DHA showed 
a sex and age dependent (P<0.0001).  At weaning, male offspring had a higher percentage 
of DHA than female offspring (P<0.05); however, from weaning to 16 weeks, male DHA 
decreased to the levels similar to the females.  There was no effect of diet on the PL DHA 
composition at weaning or 16 weeks in the male and female offspring.   
3.5 Effect of diets high or low in n-3 PUFA on the mRNA expression of BDNF and 
TrkB of the brainstem 
 The effects of perinatal and postweaning diets high or low in n-3 PUFA on 
brainstem mRNA expression of BDNF and TrkB were determined using real-time qPCR. 
There was no independent significant effect of diet, age, and sex on brainstem BDNF 
mRNA expression (Figure 3.3A).  Interestingly, there was a significant interaction 
between sex and age on BDNF mRNA expression (P<0.05) (Figure 3.3A).  At weaning, 
females had a higher mRNA expression of BDNF compared to males (P<0.05) (Figure 
3.3A); however, the expression of BDNF decreased from weaning to 16 weeks 
postweaning in the females (P<0.05) (Figure 3.3A).  There was no significant 
independent effect of sex, age, and diet on brainstem TrkB mRNA expression (Figure 
3.3B).   
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Table 3.8: Effects of a diet high or low in n-3 PUFA on the phospholipid n-3 
polyunsaturated fatty acid composition of the brainstem from male and female 
offspring at weaning and 16 weeks postweaning 
.
 ͺʹ 
Data are expressed as weight percentage of the total extracted phospholipid fatty acids.  Mean  SD, n=8.  Main effects and 
interactions were determined by three-way ANOVA; pairwise comparisons using Bonferroni correction was used to determine 
differences when there was an observed statistical significant interaction.  Within a column, statistically significant values are 
marked with unlike superscripts when a significant interaction was observed (P<0.05) between sex and age (a,b) .  ALA = alpha-
linolenic acid; EPA = eicosapentaenoic acid; DHA = docosahexaenoic acid; NS= non-significant; ND = not detected. 
 N-3 PUFA (%w/w) 
       
    
C18:3n-3 (ALA) C20:5n-3 (EPA) C22:5n-3 C22:6n-3 (DHA) 
Male   Weaning High n-3 ND ND ND 14.73 ± 1.67a 
   Low n-3  ND ND ND 13.13 ± 1.10a 
          16 Weeks High n-3  ND ND ND 11.07 ± 1.29b 
   Low n-3  ND ND ND 11.63 ± 1.87b 
        Female   Weaning High n-3  ND ND ND 9.84 ± 1.26b 
   Low n-3  ND ND ND 10.01 ± 0.68b 
          16 Weeks High n-3  ND ND ND 11.98 ± 0.68b 
   Low n-3  ND ND ND 10.58 ± 1.32b 
        Sex    
   
P < 0.0001 
Diet     
   
NS 
Age    
   
NS 
Sex*Diet   
   
NS 
Sex*Age   
   
P < 0.0001 
Diet*Age   
   
NS 
Sex*Diet*Age         P < 0.05 
 ͺ͵ 
 
 
 
 
 
Figure 3.3: Effects of a diet high or low in n-3 PUFA on the mRNA expression of 
brain-derived neurotrophic factor and tropomyosin-receptor kinase B  in the 
brainstem:  Data represents female and male cerebellar mRNA expression of brain-
derived neurotrophic factor (BDNF) (A) and tropomyosin-receptor kinase B (TrkB) (B) at 
weaning and 16 weeks, normalized with -actin as the house-keeping gene.  Main effects 
and interactions were determined by three-way ANOVA; pairwise comparisons using 
Bonferroni correction was used to determine differences when there was an observed 
statistical significant interaction.  Statistically significant values are marked with unlike 
letters (a,b) when a significant interaction was observed (P<0.05) between sex and age.  
Mean (n=8)  SD.  NS = non-significant.  
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3.6 Effects of a diet high or low in n-3 PUFA on the mRNA expressions of SCD1 
and MBP of the brainstem              
      The effects of a perinatal and postweaning diet high or low in n-3 PUFA on 
myelin-related genes in the brainstem was assessed using real-time qPCR analysis of 
SCD1 and MBP mRNA expression.  There was a significant interaction between sex and 
age (P<0.05) (Figure 3.4A), and diet and age (P<0.0001) (Figure 3.4A) on the mRNA 
expression of SCD1 in the brainstem.  Interestingly, brainstem SCD1 mRNA expression 
increased from weaning to 16 weeks in males only (P<0.05) (Figure 3.4A), which was 
higher compared to females at 16 weeks (P<0.05) (Figure 3.4A).  Furthermore, at 16 
weeks, the male offspring fed a diet high in n-3 PUFA had a higher mRNA expression of 
SCD1 compared to the low n-3 PUFA diet group (P<0.05) (Figure 3.4A); however, this 
effect was not seen in the female brainstem.  There was a significant independent effect of 
age on the mRNA expression of MBP in the brainstem (P<0.0001) (Figure 3.4B).  There 
was a decrease in the brainstem mRNA expression of MBP from weaning to 16 weeks in 
both the male and female offspring (P<0.0001) (Figure 3.4B).  There was a significant 
independent effect of age on the mRNA expression of MBP in the brainstem (P<0.0001) 
(Figure 3.4B).  There was a decrease in the brainstem mRNA expression of MBP from 
weaning to 16 weeks in both the male and female offspring (P<0.0001) (Figure 3.4B). 
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Figure 3.4: Effects of a diet high or low in n-3 PUFA on the mRNA expression of 
stearoyl-CoA desaturase-1 and myelin basic protein in the brainstem:  Data represents 
female and male cerebellar mRNA expression of stearoyl-CoA desaturase-1 (SCD1) (A) 
and myelin basic protein (MBP) (B) at weaning and 16 weeks, normalized with -actin 
as the house-keeping gene.  Main effects and interactions were determined by three-way 
ANOVA; pairwise comparisons using Bonferroni correction was used to determine 
differences when there was an observed statistical significant interaction.  Statistically 
significant values are marked with unlike superscripts when a significant interaction 
was observed (P<0.05) between sex and age (a,b) and diet and age (A,B).   Mean (n=8) 
 SD.  NS = non-significant.  
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3.7 Effects of a diet high or low in n-3 PUFA on the adult female cortical 
phospholipid fatty acid composition 
 The cerebral cortical PL composition of the adult female, obtained from feeding a 
diet high or low in n-3 PUFA, for one month or two months is given in Table 3.9.  There 
was an independent effect of diet on C16:0 and C18:0, where a diet high in n-3 PUFA 
increased C16:0 and C18:0, compared to a diet low in n-3 PUFA for both one and two 
month feeding period (P<0.01).  There was an independent effect of age on the PL C14:0 
(P<0.01) and total SFA (P<0.01).  Cortical PL total SFA and C14:0 decreased from the 
one month feeding to the two month feeding in both the high and low n-3 PUFA diet 
group.  
Diet and age were shown to have no effect on the PL total MUFA, specifically 
C18:1 and C20:1n-9; however, a diet high in n-3 PUFA increased the accretion of PL 
C16:1n-7 (P<0.05).  There was no effect of age on the accretion of PL C16:1n-7 in the 
female cerebral cortex.  
 There was a significant independent effect of age and diet on the total PL n-6 
PUFA and AA amount in the female cerebral cortex (P<0.001).  A diet high in n-3 PUFA, 
fed for either one or two months, reduced the amount of total PL n-6 PUFA and AA, 
compared to the low n-3 PUFA diet group (P<0.001).  On the other hand, the amount of 
PL total n-6 and AA was higher in the cerebral cortex at two months compared to the one 
month group (P<0.001).  Diet showed an independent effect on the cortical ADA 
accretion (P<0.001), where females fed a diet high in n-3 PUFA showed lower levels of 
ADA compared to the low n-3 PUFA group, at both one month and two months 
(P<0.001).  
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Table 3.9: Effects of a diet high or low in n-3 PUFA on the adult female cortical 
phospholipid fatty acid composition after being fed for one or two months  
 
 
 
 
 
 
 
 ͻͲ 
Expressed as weight percentage of the total extracted phospholipid fatty acids.  Mean  SD, n=6.  Main effects and interactions 
were determined by two-way ANOVA; pairwise comparisons using Bonferroni correction was used to determine differences 
when there was an observed statistical significant interaction.  Within a row, statistically significant values are marked with 
unlike superscripts (a,b) when a significant interaction was observed (P<0.05) between diet and age.  LA = linoleic acid; ALA = 
alpha-linolenic acid; DHA = docosahexaenoic acid; AA = arachidonic acid; EPA = eicosapentaenoic acid; ADA = adrenic 
acid; ΣSFA = sum of saturated fatty acids; ΣMUFA = sum of monounsaturated fatty acids; Σn-6 PUFA = sum of omega-6 
polyunsaturated fatty acids; NS= non-significant; ND = not detected. 
                               1 Month   2 Month                      Main Effects 
Fatty Acids 
(%w/w) High n-3 Low n-3  High n-3  Low n-3  
 
Diet 
 
Age 
 
Diet*Age  
C14:0 0.3 ± 0.12 0.23 ± 0.05 0.16 ± 0.03 0.13 ± 0.01 NS P<0.001 NS  
C16:0 24.67 ± 1.00 22.70 ± 1.7 22.89 ±0.54 22.71 ± 0.26 P<0.05 NS  NS  
C18:0 25.10 ± 1.25 24.50 ± 1.80 23.49 ± 0.40 23.58 ± 0.42 P<0.05 NS  NS  
ΣSFA 50.10 ± 1.38 47.47 ± 3.10 46.53 ± 0.66 46.41 ± 0.61 NS  P<0.01 NS  
C16:1n-7 0.56 ± 0.18 0.47 ± 0.06 0.60 ± 0.03 0.51 ± 0.03 P<0.05 NS  NS  
C18:1 20.32 ± 0.43 19.33 ± 2.62 18.97 ± 1.09 18.52 ± 1.14 NS  NS  NS  
C20:1n-9 1.51 ± 0.50 1.51 ±  0.66 1.22 ± 0.32 1.24 ± 0.29 NS  NS  NS  
ΣMUFA 22.41 ± 1.66 21.32 ± 3.21 20.80 ± 1.38 20.26 ± 1.46 NS  NS  NS  
C18:2n-6 (LA) 1.10 ± 0.20 0.92 ± 0.1 1.00 ± 0.07 0.95 ± 0.07 NS  NS  NS  
C20:4n-6 (AA) 8.55 ± 0.77 9.96 ± 0.55 10.27 ± 0.72 11.59 ± 0.96 P<0.001 P<0.0001 NS  
C22:4n-6 (ADA) 2.34 ± 0.28 3.05 ± 0.33 2.45 ± 0.14 3.07 ± 0.32 P<0.0001 NS  NS  
Σn-6  11.94 ± 1.04 13.80 ± 0.64 13.73 ± 0.80 15.60 ± 1.26 P<0.0005  P<0.0005 NS  
C18:3n-3 (ALA) ND ND 0.05 ± 0.01 ND    C20:5n-3 (EPA) ND ND 0.49 ± 0.90 ND    C22:5n-3 0.29 ± 0.02 0.07 ± 0.05 0.33 ± 0.08 ND P<0.0001 NS NS 
C22:6n-3 (DHA) 15.29 ± 1.61b 16.78 ± 1.00ab 18.18 ± 0.30a 17.72 ± 0.58a NS P<0.0005 P<0.05 
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 There was a significant interaction observed between diet and age for the cortical 
PL DHA (P<0.05).  Independently, diet had no effect on PL DHA at weaning or 16 
weeks; however, a diet high in n-3 PUFA caused a higher accretion of PL DHA at two 
months compared to the one month group (P<0.05).  Furthermore, there was an increase 
in the accretion of DHA in the animals at two months compared to the one month group 
(P<0.05).  Interestingly, ALA and EPA were not detected in female cortical PL at one 
month.  However, both ALA and EPA were detected at two months after feeding a diet 
high in n-3 PUFA (statistical analysis could not be performed for these fatty acids due to 
no detection for some treatments).  Finally, a diet high in n-3 PUFA increased cortical PL 
C22:5n-3 levels at both one month and two month feeding periods, compared to the low 
n-3 PUFA diet group (P<0.0001).    
3.8 Investigating the effects of specific fatty acids on the regulation of gene 
expression of BDNF, TrkB, SCD1 and MBP using primary cerebral cortical cells 
3.8.1. Effects of various concentrations of DHA on cell viability of primary cerebral 
cortical cells  
 The effect of DHA treatment at varying concentrations on primary cerebral 
cortical cell viability was assessed using the MTT assay.  The percent viability of cerebral 
cortical cells treated with 10, 25, 50, 75, 100, and 250 M of DHA was not statistically 
different from the control cells treated with vehicle alone (Figure 3.5).  However, the 
viability of cerebral cortical cells decreased after treatment with 500 M DHA compared 
to vehicle control (P<0.05) (Figure 3.5).  
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Figure 3.5: Effects of various concentrations of docosahexaenoic acid treatments on 
cell viability of primary cerebral cortical cells:  The viability of cerebral cortical cells 
were measured using MTT assay after treatment with various concentrations of 
docosahexaenoic acid (DHA) as explained in the methods section.  Data was assessed 
using one-way ANOVA to determine significance (P<0.05).  Significant effects were 
further analyzed using Bonferroni post-hoc test.  Cell viability was calculated by 
comparing DHA treatment groups to vehicle control (VC).  Values are expressed as mean 
(n=4)  SD.  (* = P<0.05).   
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3.8.2. Treatment of primary cortical cells with DHA increased the accretion of DHA 
in the phospholipid fraction    
 The PL fatty acid composition of cerebral cortical cells is reported in Table 3.10.  
There was no significant effect of various concentrations of DHA (10, 25, 50, 75, and 100 
M) on the PL fatty acid composition of total and individual SFAs.  There was a decrease  
in C16:1n-7 after treatment of cortical cells with 75 and 100 M DHA compared to the 
vehicle control (P<0.05).  However, total MUFA and C18:1 was not changed after DHA 
treatments compared to the control cells.  Interestingly, there was a decrease in AA after 
treatment with 50 and 100 M DHA (P<0.05); compared to control.  Treatment with 
DHA at higher concentrations (50, 75, and 100 M) significantly increased the 
percentage of PL DHA in the cerebral cortical cells compared to vehicle control (P<0.05).  
However a dose of 75 and 100 M showed no further increase compared to 50 M, thus 
for the future experiments, a dose of 50 M DHA treatment was used.  
3.8.3 Effects of DHA and AA treatment on primary cerebral cortical cells BDNF and 
TrkB mRNA expression 
 The effect of DHA and AA treatment on cerebral cortical cell BDNF and TrkB 
mRNA expression was assessed using real-time qPCR analysis.  Treatment with DHA 
significantly increased the mRNA expression of BDNF compared to vehicle control and 
AA treated cells (P<0.05) (Figure 3.6).  In contrast, the mRNA expression of BDNF of 
cells treated with AA was not statistically different from cells treated with the vehicle 
control (Figure 3.6).  There was also a significant increase in the mRNA expression of 
TrkB for cells treated with DHA, compared to vehicle control (P<0.05) (Figure 3.7).  AA  
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Table 3.10: Effects of various concentrations of docosahexaenoic acid  treatments on 
primary cerebral cortical cells phospholipid fatty acid composition 
 ͻ͸ 
Data are expressed as weight percentage of the total extracted phospholipid fatty acids.  Mean  SD, n=3.  Main effects and 
interactions were determined by one-way ANOVA.  Significant effects were further analyzed using Bonferroni post-hoc test.  
Mean values within a row marked with unlike superscripts (a,b) were significantly different (P<0.05).  ALA = alpha-linolenic 
acid; LA = linoleic acid; ADA = adrenic acid; EPA = eicosapentanoic aicd; AA = arachidonic acid; DHA = 
docosahexaenoic acid; ΣSFA = sum of saturated fatty acids, ΣMUFA = sum of monounsaturated fatty acids, Σn-6 PUFA = 
sum of omega-6 polyunsaturated fatty acids, Σn-3 PUFA = sum of omega-3 polyunsaturated fatty acids, ND = not detected. 
 
 
 
 
 
 
 
 
 
DHA Treatments 
Fatty Acids 
 (%w/w)   Vehicle   10 µM    25 µM    50 µM    75 µM    100 µM  
C14:0 0.73 ± 0.63 1.25 ± 0.28 1.24 ± 0.21 1.04 ± 0.17 0.64 ± 0.57 0.39 ± 0.67 
C16:0 29.71 ± 1.63 29.50 ±  0.98 30.16 ± 0.30 29.37±  0.17 29.43 ± 0.33 30.12 ± 0.50 
C18:0 22.7 ± 2.19 22.41 ± 0.54 19.29 ± 0.65 19.24 ± 1.18 20.75 ± 1.52 21.56 ± 2.30 
ΣSFA 53.13 ± 2.61 53.17 ± 0.91 50.69 ±  0.48 49.65±  1.06 50.82 ± 1.89 52.06 ± 2.64 
C16:1n-7 6.09 ± 1.18a 5.88 ± 0.16a 5.96 ± 0.68a 5.77 ±  0.09a 4.66 ± 0.23b 4.26 ± 0.24b 
C18:1 27.99 ± 0.78 26.84 ± 0.55 28.89 ±  0.88 29.3±  0.6 28.07± 1.59 27.13 ± 1.99 
C20:1n-9 ND ND ND ND ND ND 
ΣMUFA 34.08 ± 1.76 32.71 ± 0.65 34.85 ± 1.5 35.07±  0.66 32.7± 21.80 31.4 ± 2.21 
C18:2n-6 (LA) ND ND ND ND ND ND 
C20:4n-6 (AA) 6.27 ± 0.38 5.77 ± 0.39bc 6.14 ± 0.23 6.0 ±  0.07b 6.73 ± 0.12a 5.94 ±  0.31c 
C22:4n-6 (ADA) ND ND ND ND ND ND 
Σn-6 PUFA 6.27 ± 0.38 5.77 ± 0.39 6.14 ± 0.23 6.0 ±  0.07 6.73 ± 0.12 5.94 ± 0.31 
C18:3n-3 (ALA) ND ND ND ND ND ND 
C20:5n-3 (EPA) ND ND ND ND ND ND 
C22:5n-3 ND ND ND ND ND ND 
C22:6n-3 (DHA) 6.52 ± 0.86 8.34 ± 1.21 8.32 ± 1.21 9.27 ± 1.76b 9.72 ± 0.35b 10.60 ± 0.43a 
Σn-3 PUFA 6.52 ± 0.86 8.34 ± 1.21 8.32 ± 1.21 9.27 ± 1.76 9.72 ± 0.35 10.60 ± 0.43 
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Figure 3.6: Effect of docosahexaenoic acid and arachidonic acid treatment on primary 
cerebral cortical cells brain-derived neurotrophic factor mRNA expression:  Cerebral 
cortical cell brain-derived neurotrophic factor (BDNF) mRNA expression after treatment 
with 50 M docosahexaenoic acid (DHA) and arachidonic acid (AA) was assessed using 
real-time qPCR, as explained in the method section.  Data were assessed using one-way 
ANOVA to determine significance (P<0.05).  Significant effects were further analyzed 
using Bonferroni post-hoc test.  Mean values were marked with unlike letters (a,b) when 
significantly different (P<0.05).  BDNF mRNA expression was normalized with -actin as 
the house-keeping gene.  Values are expressed as mean (n=3)  SD.  VC = Vehicle 
control.   
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Figure 3.7: Effect of docosahexaenoic acid and arachidonic acid treatment on primary 
cerebral cortical cells tropomyosin-receptor kinase B mRNA expression:  Cerebral 
cortical cell tropomyosin-receptor kinase B (TrkB) mRNA expression after treatment with 
50 M docosahexaenoic acid (DHA) and arachidonic acid (AA) was assessed using real-
time qPCR, as explained in the method section.  Data were assessed using one-way 
ANOVA to determine significance (P<0.05).  Significant effects were further analyzed 
using Bonferroni post-hoc test.  Mean values were marked with unlike letters (a,b) when 
significantly different (P<0.05).  TrkB gene expression was normalized with -actin as 
the house-keeping gene.  Values are expressed as mean (n=3)  SD.  VC = Vehicle 
control.   
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treatment had no significant effect on TrkB mRNA expression compared to DHA 
treatment and vehicle control (Figure 3.7).  
3.8.4 Effects of DHA and AA treatment on primary cerebral cortical cells SCD1 and 
MBP mRNA expression 
The effect of DHA and AA treatment on cerebral cortical cell mRNA expression 
of SCD1 and MBP was determined using real-time qPCR analysis.  Treatment with DHA 
showed a significant increase in the mRNA expression of SCD1 (P<0.05) (Figure 3.8).  In 
addition, DHA treatment resulted in a significantly higher SCD1 mRNA expression in the 
cerebral cortical neurons compared to AA treatment (P<0.05) (Figure 3.8).  However, the 
mRNA expression of SCD1 after AA treatment was not significantly different from the 
vehicle control (Figure 3.8).  DHA treatment also significantly increased the mRNA 
expression MBP (P<0.05) (Figure 3.9) compared to cells treated with the vehicle control.  
In addition, the mRNA expression of MBP was not significantly different between DHA 
and AA treatment (Figure 3.9).     
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Figure 3.8: Effect of docosahexaenoic acid and arachidonic acid treatment on primary 
cerebral cortical cells stearoyl-CoA desaturase-1 mRNA expression:  Cerebral cortical 
cell stearoyl-CoA desaturase-1 (SCD1) mRNA expression after treatment with 50 M 
docosahexaenoic acid (DHA) and arachidonic acid (AA) was assessed using real-time 
qPCR, as explained in the method section.  Data were assessed using one-way ANOVA to 
determine significance (P<0.05).  Significant effects were further analyzed using 
Bonferroni post-hoc test.  Mean values were marked with unlike letters (a,b) when 
significantly different (P<0.05).  SCD1 gene expression was normalized with -actin as 
the house-keeping gene.  Values are expressed as mean (n=3)  SD.  VC = Vehicle 
control.   
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Figure 3.9: Effect of docosahexaenoic acid and arachidonic acid treatment on primary 
cerebral cortical cells myelin basic protein mRNA expression:  Cerebral cortical cell 
myelin basic protein (MBP) mRNA expression after treatment with 50 M 
docosahexaenoic acid (DHA) and arachidonic acid (AA) was assessed using real-time 
qPCR, as explained in the method section.  Data were assessed using one-way ANOVA to 
determine significance (P<0.05).  Significant effects were further analyzed using 
Bonferroni post-hoc test.  Mean values were marked with unlike letters (a,b) when 
significantly different (P<0.05).  MBP gene expression was normalized with -actin as 
the house-keeping gene.  Values are expressed as mean (n=3)  SD.  VC = Vehicle 
control.  
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Chapter 4: Discussion 
 
4.1 Effects of a diet high or low in n-3 PUFA on the phospholipid fatty acid 
composition of various regions of the brain 
The adequate consumption of PUFA is important for the proper development of 
the neuronal membranes (Clandinin et al., 1980).  Furthermore, there is a high accretion 
of AA and DHA during the last trimester of pregnancy and early postnatal period, a time-
point corresponding to the rapid development of the brain (Arbuckle & Innis, 1992; 
Wainwright, 2002).  In rodents, this period corresponds to the last three days of gestation 
and up to the first prenatal week (Clandinin et al., 1980; Green & Yavin, 1996).  Our 
laboratory has previously shown that a perinatal and postweaning diet high in n-3 PUFA 
increased the accretion of DHA in the cerebral cortex of male offspring, compared to 
male mice fed a low n-3 PUFA diet (Balogun & Cheema, 2014).  Specific regions of the 
brain have a specific fatty acid composition (Carrié et al., 2000), which may be important 
for their function.  Although several studies have focused on the effect of diets high in n-3 
PUFA on cortical fatty acid compositions, there are no studies to date to show the effects 
of diets high in n-3 PUFA on the fatty acid composition of other regions of the brain.  
This thesis focused on the effects of diets high or low in n-3 PUFA on the fatty acid 
composition of cerebellum and brainstem.  
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4.1.1 Effects of a diet high or low in n-3 PUFA on the phospholipid fatty acid 
composition of the cerebellum 
 We investigated the effects of a perinatal and postweaning diet high in n-3 PUFA 
on the cerebellar PL fatty acid composition in both male and female offspring to delineate 
sex-specific effects at weaning and 16 weeks postnatal.  
4.1.1.1 Effect of diets high or low in n-3 PUFA on SFA and MUFA composition of the 
cerebellum 
Patients diagnosed with a neuropsychiatric disease show changes in the SFA and 
MUFA PL fatty acid composition of the brain (Hamazaki et al., 2012; McNamara et al., 
2014).  We observed a decrease in total SFA, and an increase in total MUFA, particularly 
C18:1 in male and female cerebellum from weaning to 16 weeks.  Multiple rodent and 
human studies have also observed the same effect of age on the whole brain and 
cerebellum PL SFA and MUFA content (Carrié et al., 2000; Xiao et al., 2005; Martinez 
& Mougan, 1998).  However, we are the first to assess the sex-specific differences in SFA 
and MUFA PL fatty acid composition of the cerebellum.  
 The accumulation of SFA and MUFA in the developing brain has been attributed 
to de novo synthesis rather than transport from the peripheral pool (Edmond et al., 1998). 
We made novel observations showing that a longer exposure to a diet high in n-3 PUFA 
increased cerebellar PL C18:1 in both male and females, compared to mice fed a low n-3 
PUFA diet.  An increase in C18:1 may be due to an increase in the expression or activity 
of the enzymes responsible for the desaturation and elongation of SFAs into MUFAs in 
the cerebellum, particularly C18:1.  A possible explanation is the association of n-3 
PUFAs with the rate-limiting enzyme SCD1.  It has previously been shown that feeding a 
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diet high in ALA increased the mRNA expression of SCD1 in male rats compared to the 
standard chow diet (Cintra et al., 2012), which is similar to our findings.   
Interestingly, the amygdala from post-mortem MDD patients had higher amounts 
of C16:0, and lower amounts of C18:1, compared to control subjects (Hamazaki et al., 
2012).  Furthermore, McNamara & Liu (2011) found a reduction in human SCD mRNA 
expression in the prefrontal cortex of patients with MDD, compared to control.  Our 
results suggest that one of the underlying mechanisms by which n-3 PUFA may promote 
beneficial health effects on neuropsychiatric illnesses due to the regulation of SFA and 
MUFA metabolism via SCD1 gene expression, which is discussed further in Section 
4.1.2.1. 
4.1.1.2 Effect of diets high or low in n-3 PUFA on the n-6 and n-3 PUFA composition 
of the cerebellum 
A perinatal and sustained postweaning diet high in n-3 PUFA increased the 
accretion of DHA in both male and female cerebellum, compared to the low n-3 PUFA 
diet group, similar to our previously published findings in the cortex (Balogun & 
Cheema, 2014).  Xiao et al. (2005) also reported similar findings where a perinatal and 
postweaning diet supplemented with n-3 PUFA increased the accretion of DHA in the 
five-week-old male rat offspring cerebellum, compared to a diet deficient in n-3 PUFA.  
However, these authors only studied the male offspring, and the diet adequate with n-3 
PUFA was comprised of only 3.5 % ALA, which is comparable to the levels in a standard 
chow diet (Xiao et al., 2005).  Furthermore, we report for the first time an age and sex-
specific effect of DHA accretion in the cerebellum PLs.  At weaning, female offspring 
had lower accretion of PL DHA compared to the male offspring; however, as the females 
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aged from weaning to 16 weeks, the accretion of DHA increased, and was similar to that 
of the males.  A plausible explanation for the sex specific difference may be due to an 
increase in the desaturation and elongation of ALA to DHA in young adult female mice, 
which is regulated by estrogens (Childs et al., 2008; Alessandri et al., 2008). 
It was obvious that a diet high in n-3 PUFA caused a decrease in AA in the 
cerebellum PLs.  There was an independent effect of diet and age on the cerebellar PL n-6 
PUFA AA and ADA, where a diet high in n-3 PUFA caused a decrease in cerebellar AA 
and ADA in both male and female offspring, compared to the low n-3 PUFA diet group.  
Moreover, both male and female offspring showed a decrease in AA and ADA from 
weaning to 16 weeks, which is similar to our previous results on the PL fatty acid profile 
of the male cerebral cortex (Balogun & Cheema, 2014).  Demar et al. (2006) found a 
decrease in LA elongation and desaturation in adult rodent brains, and most of the LA 
utilized by the brain was β-oxidized into downstream aqueous products.  Thus, a decrease 
in AA and ADA from weaning to 16 weeks postweaning in our study is likely due to a 
decrease in the desaturation and elongation process during ageing. 
Elongation and desaturation of n-3 and n-6 PUFAs are carried out by fatty acid 
desaturases (FADS) and elongases (ELOVL).  Interestingly, postmortem studies have 
observed altered expression of these genes in the prefrontal cortex of patients with 
schizophrenia (Liu et al., 2009) and MDD (McNamara and Liu, 2011).  Therefore, 
alterations in n-3 and n-6 PUFA fatty acid synthesis and composition of the brain have 
been linked to neuropsychiatric illnesses.  Although we did not measure the gene 
expression of FADS and ELOVL, we postulate the sex and age-specific differences are 
likely due to differential regulation of these enzymes.  The gene expression of FADS and 
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ELOVL is regulated by estradiol (Marks et al., 2013), which may explain the sex-specific 
effects we observed.  Whether the gene expression of FADS and ELOVL are age and 
brain region specific is unknown and requires future study.  
4.1.2 Effects of a diet high or low in n-3 PUFA on the phospholipid fatty acid 
composition of the brainstem 
 The brainstem is a region of the brain that comprises the pons, medulla oblongata, 
and the mid-brain.  Brainstem-related symptoms, such as gait and balance impairment 
(Golbe, 2001), as well as depression (Rub et al., 2000) in Alzheimer’s patients suggests 
the brainstem to play a role in the pathogenesis of Alzheimer’s disease (Morcinek et al., 
2013).  Moreover, studies have shown an association between n-3 PUFA supplementation 
and Alzheimer’s disease (Green et al. 2006; Luchtman & Song, 2013; Kiso, 2011).  
However, no study to date has determined the effects of a diet high and low in n-3 PUFA 
on the alterations in the fatty acid composition of the brainstem.  We determined the PL 
fatty acid composition of the brainstem of male and female offspring fed a diet high or 
low in n-3 PUFA at weaning and 16 weeks postweaning. 
4.1.2.1 Effect of diets high or low in n-3 PUFA on SFA and MUFA composition of the 
brainstem 
   Total SFA decreased, while C18:1 increased from weaning to 16 weeks in the 
brainstem in both male and female offspring.  However, unlike the cerebellum, there was 
no effect of a diet high in n-3 PUFA on MUFA and SFA content of the brainstem at both 
weaning and 16 weeks in both sexes.  This may be due to the specific PL fatty acid 
composition of each region of the brain (Chavko et al., 1993; Svennerholm, 1968).  In the 
current study, we assessed the fatty acid composition of total extracted PL classes.  
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However, the PLs that primarily make-up the neuronal membrane are PC, PI, PS, PE and 
Sph (Svennerholm, 1968).  Moreover, the most abundant PL in the brain is PE and PC 
(Sun & Horrocks, 1967).  Interestingly, compared to gray matter, adult white matter PE 
and PC are sparse in DHA, but are highly enriched with MUFA and SFA (Kishimoto et 
al., 1969; Svennerholm, 1968).  The brainstem has the highest amount of white matter, 
followed by the cerebellum, thus having less PC and PE and less DHA (Chavko et al., 
1993; Svennerholm, 1968).  Therefore, a plausible explanation for the region-specific 
differences seen with a perinatal and postweaning diet high n-3 PUFA may be due to the 
enrichment of neuronal membrane PL DHA in the brainstem, compared to the 
cerebellum.  This is further discussed when assessing the brainstem PL n-6 and n-3 PUFA 
in section 4.1.2.2.  
4.1.2.2 Effect of diets high or low in n-3 PUFA on the n-6 and n-3 PUFA composition 
of the brainstem 
 Our laboratory has previously established that the accretion of cortical PL total n-
6 PUFA decreases with age (Balogun & Cheema, 2014).  In the current study, we found 
that the amount of PL total n-6 PUFA, AA and LA in the brainstem decreased with age in 
both male and females.  Our findings are similar to the observations of Xiao et al. (2005), 
who reported a reduction in LA and AA in the medulla oblongata and midbrain regions of 
the brainstem after feeding female rats a standard chow diet from 3 days post-birth, 21 
days, 10 weeks, and up until 18 months of age.  The most notable finding was that a high 
n-3 PUFA diet decreased PL ADA in both male and female offspring at weaning and 16 
weeks, compared to the low n-3 PUFA diet group; however, a high n-3 PUFA diet was 
only shown to have an effect on LA and AA at 16 weeks in both the male and female 
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brainstem.  A plausible explanation for this may be due to the changes in PL classes 
during brain development (Svennerholm, 1968).  The brainstem consists of mostly white 
matter, whereas the cerebellum has a gray matter outer core, and an inner region 
composed of white matter (Chavko et al., 1993).  Furthermore, gray matter and white 
matter are comprised of different PL classes, whose fatty acid compostion changes with 
development (Svennerholm, 1968).  Specifically, as the fetal brain matures, the DHA 
esterified to the PL classes PS and PE, embedded in the white matter, are reduced in the 
white matter (Svennerholm, 1968).  In our study, we isolated and assessed total PL of the 
brainstem neuronal membrane, which is comprised of mostly white matter, thus having 
only limited amounts of PL classes esterified with DHA.  Therefore, the effects of a diet 
high in n-3 PUFA may be diluted when measuring the fatty acid composition of total PLs 
from the brainstem due to the low amount of  specific PL with esterfied DHA.    
 The PL DHA composition of the brainstem was not affected by a diet high in n-3 
PUFA; however, there was an effect of sex and age on brainstem DHA accretion.  The 
amount of DHA did not change from weaning to 16 weeks in the females, while it 
decreased in the males.  In contrast to our results, Xiao et al. (2005) reported that the 
medulla oblongata and midbrain from female rats fed a standard chow diet from weaning 
to 10 weeks had a reduction in DHA.  The differences in the results may be due to the 
isolation of the particular regions of the brainstem, whereas we isolated the full 
brainstem.  No study to date has assessed the whole or specfic-region of the brainstem in 
an age and sex-specfic manner, thus, we are the first to show the sex-specfic differences 
in brainstem DHA.  At this time, we speculate these age and sex-specific differences seen 
on DHA accretion in the brainstem are due to the male and female sex steroids (Giltay et 
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al., 2004).  A human study assessing hormone replacement therapy in tran-sexual patients 
found a reduction in the conversion of ALA to DHA in testosterone treated patients; 
however, patients treated with estradiol had a higher conversion of ALA to DHA (Giltay 
et al., 2004).  This study speculated that the n-3 PUFA conversion differences elicited by 
the hormones was due to the hormones upregulating the conversion of ALA to DHA 
(Giltay et al., 2004).  Therefore, as the males age into puberty, they have a reduction in 
the conversion of ALA to DHA, which may explain the decrease in the accretion of DHA 
in the male brainstem from weaning to 16 weeks.   
4.2 Effects of a diet high or low in n-3 PUFA on the mRNA expression of BDNF 
and TrkB in different regions of the brain  
 The neurotrophic factor, BDNF, plays a major role in the regulation of synaptic 
plasticity, neuronal survival, and mediates neuronal cell differentiation (Lewin & Barde, 
1996; Huang & Reichardt, 2001).  In addition, PUFAs play a critical role in neuronal 
signalling, particularly in the intracellular pathways tightly regulated by the neurotrophic 
factor BDNF (Yehunda et al., 2002).  Our laboratory has previously reported an increase 
in the mRNA expression of BDNF in the cerebral cortex of male offspring fed a perinatal 
and postweaning diet high in n-3 PUFA (Balogun & Cheema, 2014).  However, no study 
to date has investigated the effects of a perinatal and postweaning diet high in n-3 PUFA 
on the mRNA expression of BDNF, and its high affinity receptor TrkB, in the cerebellum 
and brainstem.  In the current study, we determined the effects of a perinatal and 
postweaning diet high or low in n-3 PUFA on the mRNA expression of BDNF and TrkB 
in the brainstem and cerebellum. 
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4.2.1 Effects of a diet high or low in n-3 PUFA on the mRNA expression of BDNF 
and TrkB in the cerebellum  
  Alterations in the expression of BDNF and its high-affinity receptor TrkB are 
associated with the underlying pathogenesis of several neuropsychiatric diseases (Li et 
al., 2015).  Although studies have shown that a diet high in n-3 PUFA increases the 
mRNA expression of BDNF in the cerebral cortex (Balogun & Cheema, 2014) and 
hippocampus (Rathod et al., 2014), it was interesting to note that a diet high in n-3 PUFA 
had no effect on the mRNA expression of BDNF and TrkB in the cerebellum.  As a diet 
high in n-3 PUFA led to an increase in PL DHA in both the cerebral cortex (Balogun & 
Cheema, 2014) and cerebellum, we postulated that this increase in PL DHA would also 
increase the expression of BDNF and TrkB as it did in the cerebral cortex.  The 
cerebellum, compared to the cerebral cortex, contains less gray matter and more white 
matter, which is deficient in PE and PS containing DHA (Chavko et al., 1993; 
Svennerholm, 1968).  However, the neuronal membrane of the cerebral cortex is highly 
enriched with PE and PC containing DHA (Chavko et al., 1993; Svennerholm, 1968).  
Therefore, the effects of a diet high in n-3 PUFA diet on the expression of BDNF and 
TrkB in the cerebellum may be reduced due to specific fatty acid composition of the PL 
in the neuronal membrane.   
4.2.1.1. Effects of age on the mRNA expression of BDNF and TrkB in the cerebellum  
The mRNA expression of BDNF in the brain decreases with age; however, each 
region of the brain has a specific age-dependent BDNF mRNA expression (Das et al., 
2001).  In our study, we found an increase in cerebellar BDNF mRNA expression from 
weaning to 16 weeks in both male and female offspring.  Diet had no effect on cerebellar 
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TrkB and BDNF mRNA expression, which was contrary to our previous findings where 
cortical BDNF mRNA expression increased in male offspring fed a diet high in n-3 
PUFA (Balogun & Cheema, 2014).  The cerebral cortex is highly enriched with DHA 
containing PS and PE, compared to the cerebellum (Chavko et al., 1993; Svennerholm, 
1968); thus we suspect the observed region-specific differences in the BDNF and TrkB 
mRNA expression are likely due to the specific PL composition of the cerebral cortex, 
compared to the cerebellum.  Therefore, future studies should isolate the specific PL 
classes of each region and quantify the specific fatty acid moieties esterified to specific 
PL species.   
Interestingly, Das et al. (2001) has previously reported a decrease in BDNF 
mRNA expression in the cerebral cortex with age, while there was an increase in BDNF 
mRNA expression with age in the cerebellum, which is consistent with our findings.  The 
age and region-specific regulation of BDNF mRNA expression was suggested to be due 
to different time points of development for each specific region (Das et al., 2001; Altman, 
1972).  For example, in the cerebellum there is an extensive amount of neurogenesis and 
neuronal differentiation during the first three weeks postnatal, compared to other regions 
of the brain (Altman, 1966).  Furthermore, this increase in neuronal growth and 
development has been shown to coincide with an increase in the mRNA expression of 
BDNF (Maisonpierre et al., 1990).  Our findings have thus confirmed that the regulation 
of BDNF gene expression is age and region specific.   
Although we found an increase in the mRNA expression of BDNF with age, there 
was a decrease in the mRNA expression of TrkB from weaning to 16 weeks, in both 
males and females.  Others have also shown a decrease in the mRNA expression of TrkB 
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from postnatal day zero and adult brains (Masana et al., 1993).  The reasoning for this 
downregulation of TrkB mRNA expression may be due to the cellular and structural 
morphology of the cerebellum (Segal et al., 1991).  Studies assessing the developing 
cerebellum have found TrkB to be highly expressed (Klein et al., 1989; Middlemas et al., 
1991); however, the inner granular cell layer of the mature cerebellum was previously 
shown to express low levels of TrkB (Lamballe et al., 1991).  Therefore, it is possible that 
immature granule cells express TrkB, but as the granular cells mature, the TrkB receptor 
expression decreases (Segal et al., 1991). 
4.2.1.2. Sex-specific effects on the mRNA expression of BDNF and TrkB in the 
cerebellum 
Sex differences have been shown to affect the expression of BDNF and TrkB in 
the forebrain and hippocampal regions of mice (Hill et al., 2012); however, it is not 
known if BDNF and TrkB mRNA expression has sex-specific regulation in the 
cerebellum.  There was no difference in BDNF mRNA expression between males and 
females.  However, there was an effect of sex on the mRNA expression of TrkB, where 
males had a higher expression than the females at both weaning and 16 weeks.  Hill et al. 
(2012) have also reported similar results in the cortex, where the protein expression of 
BDNF increased, while TrkB decreased with age in males, but there was no change in the 
females.  The sex-specific effects were due to the circulating androgens in the males.   
Patients diagnosed with bipolar disorder have a reduction in the cerebellar protein 
expression of TrkB, compared to healthy patients (Soontornniyomkij et al., 2011).  
Interestingly, females have a higher incidence of mood disorders, such as bipolar 
disorder, compared to males (Nolen-Hoeksema, 1987).  Thus, we postulate that a lower 
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gene expression of TrkB in the female cerebellum may be associated with a higher 
incidence of bipolar disorder.          
4.2.2 Effects of a diet high or low in n-3 PUFA on mRNA expression of BDNF and 
TrkB in the brainstem  
 The brainstem is an area of the brain that houses many sensory and motor tracts. 
Recent studies have implied the importance of brainstem in Alzheimer’s disease 
(Morcinek et al., 2013; Golbe, 2001; Rub et al., 2000).  The expression of BDNF is 
suggested to be high in the brainstem (Tang et al., 2010); however, no studies to date 
have assessed the effects of a diet high in n-3 PUFA on the mRNA expressed of BDNF 
and TrkB in the brainstem in a sex and age-specific manner.  In this study, we assessed 
the effects of perinatal and postweaning diets high or low in n-3 PUFA on the mRNA 
expression of BDNF and TrkB in the brainstem from male and female offspring.  There 
was no effect of diet on the mRNA expression of BDNF and TrkB in both male and 
female offspring at weaning and 16 weeks postweaning.  This was expected, as a diet 
high in n-3 PUFA had no effect on the accretion of DHA in the male and female 
brainstem.   
 There was an effect of sex and age on the mRNA expression of BDNF at weaning, 
where the BDNF mRNA expression was higher in females than males.  The effects of sex 
and age were not observed in the brainstem TrkB mRNA expression.  We are the first to 
examine the developmental differences of the TrkB receptor in the brainstem; however, 
one human study found that the various regions of the brainstem from 2-9 month old 
infants had a higher protein expression of TrkB than 46-60 year old males (Tang et al., 
2010).  Although different from our results, Tang et al. (2010) used aged adults, which 
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does not correspond to the young adult mice used in our study.  We are unable to 
determine the underlying mechanism for the sex and age-specific effects; however, we 
postulate that it may be due to the sex hormone estradiol during development.  During 
brain development, estradiol has been shown to be important in neuronal growth and 
development, which may be due to the upregulation of BDNF via estrogen (Toran-
Allerand, 1976).  Interestingly, this effect was only found in the developing brain and was 
lost in the adult brain, which may explain for observing a higher mRNA expression of 
BDNF in the females at weaning, compared to 16 weeks (Toran-Allerand, 1976).   
4.3 Effects of a diet high or low in n-3 PUFA on the mRNA expression of SCD1 
and MBP in different regions of the brain  
The fatty acid profile of the cerebellum obtained from the male and female 
offspring fed a diet high in n-3 PUFA revealed a significant interaction between age and 
diet for C18:1.  Furthermore, a diet high in n-3 PUFA has been shown to upregulate the 
expression of SCD1 in the hypothalamus (Cintra et al., 2012), which strengthens our 
findings with the increased production of cerebellar PL C18:1 after longer exposure to a 
diet high in n-3 PUFA.  This finding was quite interesting, as the brain is fully capable of 
synthesizing SFA and MUFA de novo via the rate limiting enzyme SCD1 (DeWille & 
Farmer, 1992).  One particular study suggests that SCD1 plays an important role in 
maintaining SFA and MUFA content of the brain (McNamara & Liu, 2011).  These 
authors showed a decrease in the expression of brain SCD1 in patients with 
neuropsychiatric disorders, compared to healthy control (McNamara & Liu, 2011).  A 
probable explanation for this finding could be the reduction in the conversion of SFA to 
MUFA via SCD1, which is vitally important for the formation of the myelin sheath 
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(Marbois et al., 1992).  Our finding from the cerebellum PL C18:1 provides a possible 
relationship between a diet high in n-3 PUFA and the regulation of genes involved in 
myelin formation.  Thus, in the current study, we wanted to determine the effects of a 
perinatal and postweaning diet high in n-3 PUFA effects on the mRNA expression of 
SCD1 and MBP, an essential structural protein for myelin formation, of the cerebellum 
and brainstem from male and female offspring.  
4.3.1 Effects of a diet high or low in n-3 PUFA on the mRNA expression of SCD1 
and MBP in cerebellum  
 We are the first to report an effect of a diet high in n-3 PUFA on the mRNA 
expression of SCD1 in the cerebellum of both male and female mice.  A diet high in n-3 
PUFA increased the mRNA expression of SCD1 in both male and females at weaning, 
compared to mice fed a low n-3 PUFA diet.  The gene expression of SCD1 at weaning 
coincides with the need to desaturate SFA into MUFA during myelin sheath development 
(Marbois et al., 1992).  The increase in SCD1 mRNA expression on a high n-3 PUFA, 
particularly during weaning, may aid in the formation of the developing myelin sheath.  It 
was interesting to note that only females at 16 weeks showed higher expression of SCD1 
gene expression compared to females fed the low n-3 PUFA diet.  This could have been 
due to the higher amount of total SFA in the cerebellum PL, thus requiring a higher 
expression of SCD1 to convert the higher amount of PL total SFA into MUFA.  Another 
plausible explanation for this increase in SCD1 in female offspring fed a diet high in n-3 
PUFA 16 weeks postweaning is an increase in the female sex hormones, which may have 
a synergistic effect on the expression of SCD1 in the high n-3 PUFA diet group.  No 
study to date has assessed the effect of female sex hormones in the brain and the 
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regulation of SCD1; however, one in vivo study assessing rat hepatic SCD1 found that 
estradiol and progesterone upregulate SCD1 protein expression (Marks et al., 2013).  
Furthermore, Cintra et al. (2012) also reported an increase in the protein expression of 
SCD1 in the hypothalamus of male rats fed a diet high in n-3 PUFA, thus providing 
evidence that both a diet high in n-3 PUFA and female sex hormones can alter SCD1 
protein expression.  During the process of myelination, the brain rapidly converts SFA 
into MUFA to incorporate MUFA in the developing myelin (Marbois et al., 1992).  In 
addition, myelination also requires structural proteins, such as MBP, which has been 
shown to be influenced by the intake of dietary fats (DeWille & Farmer, 1992).  MBP is 
the only structural protein found thus far to be essential in the formation of CNS myelin, 
and has been shown to coincide with myelin formation (Muse et al., 2001; Shiota et al., 
1989; Boggs, 2006).  Therefore, determining whether a diet high in n-3 PUFA alters the 
gene expression of MBP would be important.     
 There was a significant effect of diet, sex, and age on the mRNA expression of 
MBP in the cerebellum.  A diet high in n-3 PUFA increased the mRNA expression of 
MBP in males at weaning, compared to the animals fed a low n-3 PUFA diet.  On the 
other hand, a diet high in n-3 PUFA increased the mRNA expression of MBP in the 
females at 16 weeks.  It has previously been shown that the protein expression of MBP is 
upregulated in the cerebral cortex from offspring of mice fed a diet high in n-3 PUFA 
(Tian et al., 2011).  We are unable to fully explain our observations of age, sex, and diet 
on the MBP and SCD1 mRNA expression; however, we postulate that it may be due to 
the differences with male and female hormones during these two periods of development 
(Hill et al., 2012).  
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Next, we investigated whether a longer exposure to a diet high in n-3 PUFA will 
increase the mRNA expression of MBP in the cerebellum.  A diet high in n-3 PUFA 
increased the mRNA expression of MBP, which was consistent with an increase in the 
mRNA expression of SCD1 for males at weaning, and for females at 16 weeks.  This is 
an interesting observation related to sex- and age-dependent regulation of MBP and 
SCD1, which we believe could be due to the varying levels of sex hormones during 
development and needs further investigation. 
4.3.2 Effects of a diet high or low in n-3 PUFA on mRNA expression of SCD1 and 
MBP in brainstem  
 We did not find a significant effect of a diet high in n-3 PUFA on the fatty acid 
levels of SFA and MUFA in the brainstem of both female and male offspring.  A previous 
study has reported that patients who consume a diet high in n-3 PUFA prior to a traumatic 
brain injury have a faster recovery after an injury to the brainstem, compared to controls 
(Bailes & Mills, 2010).  The brainstem is a highly myelinated area of the brain (Chavok et 
al., 1993; Svennerholm, 1968; Marbois et al., 1992), thus we investigated whether a diet 
high in n-3 PUFA will have an effect on the mRNA expression of SCD1 or MBP in the 
brainstem.   
There was no effect of a diet high in n-3 PUFA on the mRNA expression of SCD1 
in the brainstem.  However, males showed an increase in the mRNA expression of SCD1 
from weaning to 16 weeks.  In addition, SCD1 mRNA expression was higher in males 
compared to the females at 16 weeks.  The sex-specific effects on SCD1 mRNA 
expression are likely due to the male androgens during development as reported 
previously by Hill et al. (2012).  Interestingly, unlike the cerebellum, a diet high in n-3 
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PUFA had no effect on the accretion of DHA in the brainstem, and SCD1 mRNA 
expression.  The brainstem contains a sparse amount of PE enriched with DHA compared 
to the cerebellum, thus, the region-specific effects of a diet high in n-3 PUFA on the 
SCD1 mRNA expression is likely due to specific fatty acid composition of PL classes in 
the cerebellum and brainstem (Chavok et al., 1993; Svennerholm, 1968).  There is no 
study to date to show whether DHA regulates the mRNA expression of SCD1 in different 
regions of the brain, which is discussed further in Section 4.5.  
 The MBP mRNA expression was affected only by age in our study, where the 
expression decreased from weaning to 16 weeks in both the males and females.  Unlike 
the cerebellum, the brainstem is the first region of the brain to develop, thus myelination 
of the rodent brainstem occurs and ends earlier than other regions of the brain, 
specifically the cerebellum (Smith, 1973).  This would explain a decrease in MBP gene 
expression from weaning to 16 weeks postweaning, compared to the cerebellum.  
 Diet did not have an effect on the brainstem MBP mRNA expression, which is 
most likely due to no change in DHA accretion in the brainstem PL because of the sparse 
amount of DHA enriched in the PL of the brainstem white matter (Chavok et al., 1993; 
Svennerholm, 1968).  The lack of an effect of a diet high in n-3 PUFA on MBP mRNA 
expression corresponds to no change in the SCD1 mRNA expression in the brainstem.   
4.4 Effects of a diet high or low in n-3 PUFA on the adult female cortical 
phospholipid fatty acid composition 
During the development of the brain, there is rapid incorporation of n-3 PUFA 
into neuronal membrane PLs, where they play important roles in neurodevelopment 
(Clandinin et al., 1980, Hoffman et al., 1993).  However, this rapid accumulation of n-3 
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PUFA has been shown to taper off in the adult brain (Moriguchi & Harauma, 2013).  In 
addition, it is thought that the adult nervous system is quite resistant to DHA losses due to 
dietary challenges (Bourre et al., 1993).  Conversely, studies assessing adult non-human 
primates have shown that a diet adequate in LA, but very low in ALA, rendered a loss in 
brain DHA (Pawlosky et al., 2001).  Therefore, the effects of a diet high in n-3 PUFA on 
adult-brain PL fatty acid composition remain controversial.  We investigated the effects 
of feeding a diet low or high in n-3 PUFA for one or two-months on the accretion of 
DHA in the cerebral cortex of adult female mice.  A longer exposure to a diet high in n-3 
PUFA increased the accretion of DHA in adult cerebral cortex, compared to that of a low 
n-3 PUFA diet group.  Adult rodent brains are capable of replacing 2-8% of the neuronal 
membrane DHA daily from the unesterfied DHA plasma pool (Rapoport et al., 2001) 
supporting our observation that a diet high in n-3 PUFA increases the accretion of DHA 
in the PL fraction of brain cortex when exposed for a longer time period.  
An increase in brain PL DHA is followed by a concomitant decrease in brain PL 
AA (Wainwright et al., 1991).  Our findings show an independent effect of diet and age 
on cortical PL total n-6 PUFA.  A diet high in n-3 PUFA caused a decrease in cortical 
total n-6 PUFA AA compared to the low n-3 PUFA diet.  Marteinsdottir et al. (1998) 
found similar results using male rats fed diets high in n-3 PUFA for two-months; 
however, these authors did not assess the effects of different time periods.  Thus, our 
findings have established that a longer exposure to a diet high in n-3 PUFA increases the 
accretion of DHA in the brain. 
 
 
 ͳʹͶ
4.5 Effects of DHA on the fatty acid accretion and mRNA expression of BDNF, 
TrkB, MBP and SCD1 in primary cortical cells in culture 
In a previous study in our laboratory, we found that a perinatal and postweaning 
diet high in n-3 PUFA increased the accretion of DHA in cerebral cortex PLs, compared 
to the low n-3 PUFA diet group (Balogun & Cheema, 2014).  This increase in cerebral 
cortex PL DHA was positively correlated with the mRNA expression of BDNF and TrkB.  
Thus, we speculate that the positive effects elicited by a diet high in n-3 PUFA are due to 
an increase in the accretion of DHA in the neuronal membrane, which will lead to an 
increase in the mRNA expression of BDNF/TrkB and genes involved in myelin 
formation.   The cerebral cortex PLs are also enriched in AA; both AA and DHA are 
required for proper development and function of the brain (Martinez et al., 1992; Stillwell 
et al., 2005).  However, AA and DHA have been shown to have different effects on the 
regulation of various signalling pathways in cortical neurons (Katakura et al., 2013).  
Since our diets contained both DHA and AA, we cannot isolate the effects of DHA and 
AA.  Therefore, we adapted a primary cortical cell culture model to investigate the 
individual effects of these fatty acids  on the mRNA expression of BDNF, TrkB, SCD1 
and MBP.   The use of primary cortical cells is a valuable technique, which more 
accurately represents the in vivo environment compared to that of established cell lines 
(Eide & McMurray, 2005).    
The primary cortical neurons treated with DHA (50, 75 and 100 μM DHA) 
showed an increase in the accretion of DHA, compared to vehicle control.  Similar 
findings have been reported  by Cao et al. (2005), who showed an increase in DHA 
accretion in PS and PE after treating rat cortical neurons with 25 M DHA for 24 hours.  
 ͳʹͷ
Our findings to show an increase in DHA accretion after treatment with DHA support our 
in vivo observations where C57BL/6N mice fed with a diet high in n-3 PUFA showed 
accretion of DHA in brain cortex (Balogun & Cheema, 2014).  Our in vitro studies have 
also established that the accretion of DHA is dose dependent. 
The treatment of cortical cells with DHA increased the mRNA expression of 
BDNF and TrkB, whereas AA had no effect on the mRNA expression of BDNF or TrkB 
compared to vehicle control, suggesting that the effect is specific to DHA.  Rao et al. 
(2007) has previously shown that DHA treatment (1.5 M) of rat primary cortical 
astrocytes increased the mRNA expression of BDNF similar to our observations with 
DHA.  These authors have further reported that the downstream inflammatory metabolites 
of AA reduce frontal cortex BDNF protein and mRNA expression (Rao et al., 2013).  
However, we did not observe an inhibition of BDNF or TrkB mRNA expression when 
cortical neuronal cells were treated with AA.  It is possible that the downstream 
metabolites of AA induce a more potent effect compared to AA.  Kou et al. (2008) has 
previously shown an increase in TrkB mRNA expression upon treatment of SH-SY5Y 
neuroblastoma cell line with EPA, an n-3 PUFA.  Bhatia et al. (2011) reported activation 
of the TrkB receptor after feeding a diet high in DHA to rats for 15 weeks, while AA had 
no effect, supporting our observation that the regulation of BDNF and TrkB pathway is 
specific towards DHA.  Future studies should focus on investigating the mechanism/s by 
which DHA regulates the gene expression of BDNF and TrkB.  
 Our in vivo data showed that a diet high in n-3 PUFA increased the accretion of 
DHA in the cerebellum, and also increased the mRNA expression of SCD1.  Thus, we 
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asked the question whether treatment of primary neuronal cortical cells with n-3 PUFA 
would have an effect on the mRNA expression of SCD1.  Interestingly, DHA treatment 
increased the mRNA expression of SCD1 in primary cortical cells, whereas AA had no 
effect, compared to vehicle control.  A previous study has reported that treatment of 
cortical neurons with 100ng/mL BDNF increased the protein expression of SCD1  
(Suzuki et al., 2012).  Our findings have shown that DHA treatment of primary cortical 
cells increased the mRNA expression of both BDNF and SCD1, thus it is possible that an 
increase in BDNF mRNA expression caused an increase in SCD1 mRNA expression, or 
vice versa.   
An increase in SCD1 gene expression is required for myelin sheath formation, 
thus we also investigated whether DHA treatment will have an effect on the mRNA 
expression of MBP.  We observed that DHA treatment increased  the mRNA expression 
of MBP in primary cortical cells, while AA had no effect, compared to vehicle control.  It 
has previously been shown that the protein expression of MBP is upregulated in the 
cerebral cortex from offspring of mice fed a diet high in n-3 PUFA (Tian et al., 2011) 
similar to our in vivo studies.  Another study using oligodendrocytes showed that AA 
treatment reduced the phosphorylation of MBP (Takeda & Soliven, 1997).  The 
phosphorylation of MBP is a post-translational modification necessary to promote proper 
structural and functional properties of the myelin membranes (Moscarello, 1990).  
Therefore, it would be interesting to compare the phosphorylation of MBP after DHA or 
AA treatment in primary cortical cells in the future studies. 
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4.6 Limitations 
 The findings of this thesis show the importance of a diet high in n-3 PUFA on the 
expression of BDNF, TrkB and genes related to myelin formation in the brain, and how 
the effects of the diet are age- and sex-specific; however the underlying cellular 
mechanisms were not explored and should be undertaken in the future.  Furthermore, we 
have only measured the gene expression of BDNF, TrkB, SCD1 and MBP; all of these 
genes are also regulated at post-transcriptional and translational level (Moscarello, 1990; 
Kaplan & Miller, 2000; Bhatia et al., 2011), which will be important to investigate in the 
future.  Lastly, it is well known that ageing has a dramatic effect on the function of the 
brain, thus it will be important to investigate whether a diet high in n-3 PUFA will have 
beneficial effects in older animals.   
 4.7 Overall Conclusion  
Overall, our findings reveal that the effects of a perinatal and postweaning diet 
high in n-3 PUFA on the brain are age, sex, and region-specific.  Our in vivo work, 
assessing the effects of a diet high in n-3 PUFA showed age and sex-specific changes in 
different regions of the brain.  Our data have established that the cerebellar accretion of n-
3 PUFA and the mRNA expression of genes related to myelin sheath formation were 
increased by a diet high in n-3 PUFA; however, these effects were not observed in the 
brainstem.  In addition, our findings have also established sex and age related effects on 
the fatty acid composition, BDNF, TrkB, SCD1 and MBP mRNA expression in specific 
regions of the brain.  Our findings have further confirmed that the brain is plastic as the 
fatty acid composition of the adult cerebral cortex can be altered, where a diet high in n-3 
PUFA can increase the accretion of DHA.   The in vitro studies have established that the 
 ͳʹͺ
effects observed in the in vivo studies are due to accretion of DHA in the brain, which 
regulates the mRNA expression of BDNF, TrkB, SCD1 and MBP.  Lastly, our findings 
show the complexity of the brain, and that factors such as diet, age, and sex need to be 
considered in neurological disorders.         
4.8 Perspectives  
We propose that the DHA-mediated increase in the gene expression of BDNF will 
lead to an increase in the SCD1 mRNA expression.  This will then increase the synthesis 
of C18:1 rendering an increase in the formation of MBP for myelin sheath formation 
(Figure 4.1).  Thus, future research should focus on elucidating the postulated 
mechanism. 
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Figure 4.1: The postulated mechanism by which docosahexaenoic acid (DHA) 
upregulates myelin formation via brain-derived neurotrophic factor (BDNF).  SCD1= 
stearoyl-CoA desaturase-1;  MBP= myelin basic protein.  
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Appendix I 
Fatty acid composition of the experimental diets 
Fatty Acids Low n-3 Medium n-3 High n-3 
    14:0 0.11 0.39 1.26 
16:0 6.32 7.43 8.71 
18:0 5.35 4.53 2.67 
∑ SFA 11.77 12.35 12.64 
    16:1n-7 0.36 0.09 2.41 
18:1 27.82 25.81 25.14 
20:1n-9 ND 0.54 0.61 
∑ MUFA 28.18 26.43 28.16 
    18:2n-6 57.73 57.03 47.86 
20:4n-6 0.11 0.14 0.23 
18:3n-6 0.04 0.04 0.10 
22:4n-6 0.09 ND 0.54 
∑ Omega-6 57.92 57.18 48.90 
    18:3n-3 0.55 0.64 0.78 
20:5n-3 0.31 1.37 3.64 
22:6n-3 0.39 1.16 3.19 
18:4n-3 0.15 0.20 0.87 
22:5n-3 0.46 0.32 0.63 
20:4n-3 0.08 0.12 0.66 
∑Omega-3 1.93 3.81 9.76 
    
Data are expressed as weight percentage of the total extracted fatty acids. Σ SFA= sum of 
saturated fatty acids, Σ MUFA= sum of monounsaturated fatty acids, Σ PUFA= sum of 
polyunsaturated fatty acids, Σ Omega-6= sum of omega-6 fatty acids, Σ Omega-3= sum 
of omega-3 fatty acids, ND= Not detected.  
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Appendix II 
Composition of the semi-purified diet designed for 20% (w/w) fat level 
  Ingredients   
Semi-Synthetic diet 
(g/kg)   
Casein 200 
DL-methionine 3 
Sucrose 305 
Corn starch 190 
Alphacel non-nutritive 
bulk 50 
Vitamin mixΨ 11 
Mineral mix* 40 
  Fat   200   
Supplied in quantities adequate to meet NRC requirements (National Research Council, 
1995). 
 
Vitamin Mix (1 kg): Thiamine hydrochloride, 0.6 g; riboflavin, 0.6 g; pyridoxine 
hydrochloride, 0.7 g; nicotinic acid, 3.0 g; d-calcium pantothenate, 1.6 g; folic acid, 0.2 
g; d-biotin, 0.02 g; cyanocobalamin (vitamin B12), 0.001 g; retinyl palmitate (vitamin A) 
pre-mix (250,000 IU/g), 1.6 g; DL-α-tocopherol acetate (250 IU/g), 20 g; cholecalciferol 
(vitamin D3, 400,000 IU/g), 0.25 g; menaquinone (vitamin K2), 0.005 g; sucrose, finely 
powdered, 972.9 g 
 
*Mineral Mix: Calcium phosphate dibasic, 500.0 g/kg; sodium chloride, 74.0 g/kg; 
potassium citrate monohydrate, 220.0 g/kg; potassium sulfate, 52.0 g/kg; magnesium 
oxide, 24.0 g/kg; manganese carbonate (43-48% Mn), 3.50 g/kg; ferric citrate (16-17% 
Fe), 6.0 g/kg; zinc carbonate (70% ZnO), 1.6 g/kg; cupric carbonate (53-55% Cu), 0.30 
g/kg; potassium iodate, 0.01 g/kg; sodium selenite, 0.01 g/kg; chromium potassium 
sulfate, 0.55 g/kg; sucrose, finely powdered, 118.0 g/kg 
